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1. Literature Review
LI Aim

Cronohacter sakazakii is an emerging infant pathogen which causes serious infections with
high mortality rates. Research on this pathogen is still in it’s infancy. This literature review
will briefly summarize the main characteristics of C. sakazakii and outline control and
prevention strategies, but the main focus will be providing details on the information available
regarding interaction of the bacterium with the host.

A secondary aim of this study is to research and document as much data as possible on C.
sakazakii as very little is known about the virulence mechanisms it this bacteria uses. C.
sakazakii uses it has only gained more attention in the last few years due to its fatal
consequences.

1.2 Introduction
The genus Cronohacter accommodates 16 biogroups of the emerging opportunistic
pathogen

known

formerly

as Enterohacter sakazakii.

Cronohacter are occasional

contaminants of milk powder and, consequently, powdered infant formula (PIT). Since it is a
pathogen that is transmitted in infant formula it represents a significant health risk to neonates.
These bacteria are opportunistic pathogens (can only cause disease when the host's resistance
is low) and are linked with life-threatening infections in neonates. Some of the clinical
symptoms of Cronohacter infection include necrotizing enterocolitis, bacteremia, and
meningitis, with case fatality rates of 50-80% being reported (Healy et al. 2010).

Infant formula manufacturers are obliged to ensure that infant formula is free of C.
sakazakii prior to sale and they are interested in developing novel C sakazakii inhibitors (e.g.
antimicrobial peptides) for incorporation into powdered infant formula (PIT) to prevent the
pathogen from causing serious illness to the host. In order to develop novel control methods

for

C.

sakazakii

(i.e.

antimicrobials/antibiotics/preservatives

etc)

a

much

greater

understanding into how C. sakazakii interacts with the host (i.e. what genes/proteins does the
pathogen use to survive within the human host) and subsequently cause disease is needed.

Compared to many other pathogens, research in this area is still in its infancy. Much is still
to be discovered about C. sakazakii and its virulence mechanisms, as well as the
protein-protein interactions that occur between this deadly pathogen and humans. The aim of
this study is to predict protein-protein interactions between C. sakazakii and human host, as
such data would greatly contribute to developing novel control methods for this pathogen and
put a stop to its destruction. The increasing availability of C. sakazakii genome sequences
from methods such as comparative analyses of the strains is contributing to further research
findings.

1.3 Characteristics and Transmission
Cronobacter pronounced (Cro.no.bac'ter) comes from the Greek word 'Cronos', who was
one of the Titans of mythology and swallowed each of his children as soon as they were bom
(Graves, 1992); and 'hacter' meaning a rod; Cronobacter a rod that can cause infection in
neonates). C. sakazakii is comprised of oxidase-negative, catalase-positive, and facultatively
anaerobic Gram-negative rods, is generally motile. C. sakazakii comprises of biogroups
7, 8, 11 and 13, of the 16 groups in total (Farmer et al. 1980). The type strain, the first to be
discovered, was originally isolated from a child’s throat (Farmer et al. 1980).

C. sakazakii is a member of the Enterobacteriaceae family. Cronobacter was first proposed
as a new genus in 2007 as a clarification of the taxonomic relationship of the biogroups found
among strains of Enterobacter sakazakii (Joseph et al. 2007). This proposal was validly
published in 2008 with 5 species and 3 subspecies named (Joseph et al. 2008). The genus
definition was further revised in 2012 with seven named species. This used the seven loci
MLST data to support the definition of two new species; C. universalis and C. condimenti
(Joseph et al. 2012). The initial four named species in 2007 were C. sakazakii (comprising
two subspecies), C. turicensis, C. miiytjensii and C. dublinensis (comprising three subspecies)

plus an unnamed species referred to s Cronobacter genomospecies 1. The taxonomy was
revised in 2008 to include a fifth nared species C. malonaticus, which in 2007 had been
regarded as a subspecies of C. sakazaki In 2012, Cronobacter genomospecies I was formally
renamed Cronobacter universalis, andi seventh species was described called Cronobacter
condimenti (Joseph et al. 2012). Th^efore, for the duration of this project, the name
Enterobacter sakazakii will no longerbe used, as the genus name Cronobacter has been
accepted in the International Journal ofystematic and Evolutionary Microbiology, as well as
a description of the new species.

All Cronobacter species, except C cndimenti, have been linked retrospectively to clinical
cases of infection in adults or infants. Te majority of Cronobacter cases occur in adults, most
often bacteraemia and have not been stdied in detail. Additionally it is associated with a rare
cause of invasive infection of infants ’ith historically high case fatality rates. It is mainly
transmitted in powdered infant formal (PIF). Multilocus sequence typing (Baldwin et al.
2009) has shown that the majority of nmatal meningitis cases in the past 30 years, across 6
countries have been associated with oly one genetic lineage of the species C. sakazakii,
called 'Sequence Type 4' or 'ST4' (Josep et al. 2011), and therefore this clone appears to be of
greatest concern with infant infections.

In infants it can cause bacteraemia, neningitis and necrotising enterocolitis. NEC is an
inflammatory intestinal disorder that abets 2-5% of all premature infants and is associated
with high mortality rates. Some nQomXdiCronobacter infections have been associated with the
use of PIF with some strains able to siwive in a desiccated state for more than two years
(Caubilla-Barron J., et al. 2007). Hcvever, not all of the cases have been linked to
contaminated PIF. In November 2011, sveral shipments of Kotex tampons had to be recalled
due to a Cronobacter contamination (Madel H., (2011).

Although C. sakazakii has been isoked from a wide variety of foods, including cheese,
meat, vegetables, grains,herbs, spices ad ultra high heated milk (Iverson et al. 2003), the
bulk of research has been concentratd on the presence of the organism in milk-based
powdered infant formula. A positive co'elation between necrotizing enterocolitis (NEC) and

oral formula feeding has been suggested (Iverson et al. 2003). The bacterium has been found
to be ubiquitous as it has been isolated from a range of different environments and foods, and
the majority of Cronobacter cases are in the adult population. Figure 1 below shows some
statistics regarding Cronobacter infections.
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Figure 1. Colonizations, symptoms, and incidence of occurrence as a percentage of total
Cronobacter infections: (a) in children and infants and (b) in adults. (Healy et al. 2010)

The association with intrinsically or extrinsically contaminated powdered infant formula
(PIF) which has attracted the main attention. In most cases, the vehicle of transmission of
Cronobacter associated with infant infections has not been confirmed.

However,

epidemiological studies in a number of incidents have implicated rehydrated PIF products as
the vehicle of transmission and utensils used for formulae preparation as the likely source of
contamination (Simmons et al. 1989, van Acker et al. 2001, Himelright et al. 2002,
Caubilla-Barron et al. 2007). C. sakazakii is able to survive in powder for at least 12 months.

Some physiological features, such as the production of a yellow pigment, the formation of a
gum-like extracellular polysaccharide ind the ability to persist in a desiccated state, suggest
an environmental niche for these or^isms. To date, the natural habitat of C sakazakii
remains unknown. In a report from 2009, the isolation and characterisation of two C
sakazakii strains from plant roots vas described. The root colonization behaviour of
Cronohacter strains originating from cinical and plant sources was also assessed (Schmid et
al. 2009). There were 9 strains investigated in total, and were found to show features that are
often found in plant-associated and nizosphere microorganisms, such as solubilization of
mineral phosphate and production of irdole acetic acid. Siderophore production was observed
for all except one strain (Schmid tt al. 2009). In addition to this, the capability to
endophytically colonize tomato and miize roots was demonstrated for several strains, either
by fluorescence in situ hybridisation, uiing fluorescently labeled oligonucleotide probes, or by
using strains that had been tagged vith a green fluorescent protein and confocal laser
scanning microscopy (Schmid et al. 2009). The results from this report have provided
evidence that plants may be the natural labitat of Cronohacter.

1.4 Details of Cronohacter Infeciions
1.4.1 Virulence

In order to assess the pathogenicity (f C. sakazakii for humans, the evaluation of potential
virulence factors is required. Up to row little has been known about the mechanisms of
pathogenicity in C. sakazakii. A necessary state in the successful colonization, establishment
and ultimately production of disease b/ microbial pathogens is the ability to adhere to host
surfaces such as mucous membranes, gastric and intestinal epithelial or endothelial tissue.
Elucidating the proteins and recepta*s involved in these interactions may permit the
development of inhibitors which could block the pathogen from adhering to these receptors
and in turn stop pathogenesis from occirring.

Virulence is the degree of pathogeniaty within a group or species of parasites as indicated
by case fatality rates and/or the ability 3f the organism to invade the tissues of the host. The

pathogenicity of an organism is determined by its virulence factors. Pathogenicity is the word
used to describe the ability of a pathogen to produce an infectious disease in an organism. It is
often used interchangeably with the term "virulence", although virulence is used more
specifically to describe the relative degree of damage done by a pathogen, or the degree of
pathogenicity caused by an organism. A pathogen can only be either pathogenic or not, and is
determined by the pathogen's ability to produce toxins, its ability to enter tissue and colonize
and its ability to spread from host to host.

Contaminated PIF has been linked, epidemiologically, with infections. Infections among
weaker, immunocompromised adults, mainly the elderly occur most often. Three principal
factors have been implicated in the pathogenesis of the disease: an immature intestinal
epithelial barrier, abnormal bacterial colonization, and formula feeding (Hunter et al. 2008). To
survive within the human host and ultimately cause disease C. sakazakii must survive transit
through the stomach (low pH), intestine (low 02, high bile, high salt levels), and also must
traverse the epithelial layer to invade and infect cells, and it must survive in the blood as it is
able to cause meningitis, must cross the blood brain barrier to cause meningitis.

In vitro virulence studies have shown that Cronohacter may survive in macrophage cells
and efficiently attach to and invade epithelial cell lines. It has been found that the production
of exopolysaccharide may contribute to the formation of biofilm, while active efflux pumps
work to promote resistance to various antimicrobial agents such as bile salts and disinfectants.
A holistic approach combining techniques such as comparative genome analysis, proteomics,
and in vivo challenges could help unravel the complex interactions between this pathogen and
its host (Healy et al. 2010). The resulting data that would be generated from such techniques
would indeed, help to identify properties in the various strains of C. sakazakii which enable
the bacterium to survive in the production environment and ultimately infect vulnerable
neonates via the food chain.

Currently there is a lack of information available on the virulence factors of C. sakazakii
and the pathogenic mechanisms involved in its neonatal infections.The translocation and
invasion of the blood-brain barrier which is formed by brain microvascular endothelial cells

(BMEC), is critical in the pathogenesis of neonatal bacterial meningitis. Because bacterial
binding of fibronectin is an initial step in the invasion of BMEC, the role of a major
surface-expressed fibronectin-binding protein of C. sakazakii in invasion of BMEC was
investigated (Nair et al. 2009). In this study, outer membrane protein A (OmpA) was
identified as a major fibronectin-binding protein of C. sakazakii, and an isogenic ompA
mutant of C. sakazakii exhibited significantly attenuated invasion in BMEC compared with
the wild-type strain (Nair et al. 2009). The findings of this study have indicated that the outer
membrane protein A, is one of the determinants that contribute to the invasion of C. sakazakii
into human BMEC in vitro, and this protein A may potentially play a role in the pathogenesis
of neonatal meningitis caused by C. sakazakii

Cronohacter invades human brain mdcro-vascular endothelial cells more often than
epithelial cells, but entry requires expression of OmpA to induce microtubule condensation.
Evidence suggests that the OmpA protein is crucial in the invasion of brain endothelial cells
by C sakazakii (Singamsetty el al. 2008). The mechanism of OmpA-mediated interaction
with brain endothelial cells has yet to be determined. Mohan and Venkitanarayanan have
shown that C. sakazakii invades moderately into human intestinal epithelial (INT407) cells,
for which ompA expression is required (Mohan Nair et al. 2007).

It is a common trait of microbial pathogens to express adherence factors responsible for
recognizing and binding to specific receptor moieties of cells, thus enabling the bacteria to
resist host strategies that would impede colonization. It has been proposed that specific
adhesion to tissue cells is therefore considered an essential virulence factor for most bacterial
pathogens (Klemm et al. 2000). Pathogen-associated molecular pattern (PAMP) molecules,
including EPS, lipoproteins, glycolipids, peptidoglycans, fatty acids, and nucleic acids of
bacteria often interact with various pattern recognition receptors known as toll-like receptors
(TLRs) (Takeda et al. 2003). Different TLR family members have been identified and are
expressed in a variety of cell types including macrophages, dendritic cells, and enterocytes
(Takeda et al. 2005). Since EPS is an outer membrane virulence factor of C. sakazakii, it is
possible that C. sakazakii interacts with enterocytes through EPS mediated binding to TER4.
Previous studies have demonstrated that EPS facilitates bacterial attachment to Caco-2 cells

and increases bacterial translocation (Deitch et al. 1987).

1.4.2 Infectious Dose

The study by Fagotto et al. (2003) was the first to describe any putative virulence factors of
C. sakazakii. The lethal dose for all of the isolates when injected intraperitoneally, was 10

o

CFU per mouse (Fagotto et al. 2003). The data has been extrapolated to estimate that the
minimum infectious dose for human infants to be 10^ CFU in a number of studies. Finding out
the exact infectious dose it takes to infect the host (not just an estimation) as well as the
specific proteins involved in infection would give us a much better insight into how we can
prevent the infection from occurring. For human neonates the oral infectious dose has been
determined to range from 10 to 10 CFU (World Health Organization 2004). Richardson et al.
(2009) has found that the CD-I mouse strain was the most susceptible of the three, with the
lowest infectious dose (10 CFU) and the lowest lethal dose (also 10“ CFU).

1.4.3 Studies with Mice

In the study by Fagotto et al. (2003), clinical and foodbome isolates of C sakazakii were
evaluated for enterotoxin production by using the suckling mouse assay. The authors
determined that 4 out of 18 strains examined tested positive enterotoxin production. Although
it is important to note that the exact role of the enterotoxin is still unclear and the genes or
single gene that code for this putative toxin are still to be identified.

Lipopolysaccharide (LFS) is a heat stable endotoxin that persists during the processing of
powdered infant formula milk. Upon ingestion it may increase the permeability of the
neonatal intestinal epithelium and consequently bacterial translocation from the gut.
Following the study into the adhesive proprieties of C. sakazakii (Mange et al. 2006), a study
by Townsend et al. (2007) was undertaken to determine the level of endotoxin present in FIF
(75 samples from 7 countries, representing 31 brands) to look at its effects on translocation.
The endotoxin levels ranged from 40 to 5.5x10"^ endotoxin units (EU)/gram and did not
correlate with the number of viable bacteria (Townsend et al. 2007), as can be seen in Figure

2.
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Figure 2. Range of endotoxin levels in powdered infant formula milk (Townsend et al. 2007).
The neonate rat model was used in order to address the risk of endotoxin-induced bacterial
translocation from the gut. Histological analysis of the colon showed marked distension of the
mucosal and muscular layers (Townsend et al. 2007). It is therefore possible that the risk of
neonatal endotoxemia and bacteraemia, more importantly in neonates with an immature
innate immune system, may be increased due to the ingestion of PIF along with high levels of
endotoxins. Also, high levels of heat-stable lipopolysaccharide (endotoxin) in PIF may
enhance the translocation of Cronohacter across the gut and blood-brain barrier (Townsend et
al. 2007).

Hunter et al. (2008) demonstrated for the first time that C. sakazakii was capable of inducing
the clinical and morphologic changes of NEC in a rat pup model. Infection with C. sakazakii
was confirmed in all surviving rat pups, as was seen from the association of GFP-labeled C.
sakazakii within the intestine and in cultures of the intestinal contents of pups fed with C.
sakazakii (Hunter et al. 2008). The enhanced pathogenesis of C. sakazakii on the compromised
intestine was shown and has particular relevance to the newborn infants who develop NEC. In
accordance with the animal findings, the effects of C. sakazakii may be especially enhanced in
the premature or hypoxic newborn (Hunter et al. 2008).

The studies demonstrated that C. sakazakii induces significant apoptosis in lEC-6 cells in
vitro and in an animal model of NEC, particularly in combination with hypoxia. However,
non-pathogenic E. coli did not increase disease severity indicating some specific traits of C.
sakazakii are responsible for the pathogenesis. C. sakazakii was found to bind to enterocytes in
rat pups at the tips of villi and to intestinal epithelial cells, IEC-6, in culture with no significant
invasion (Hunter et al. 2008) . Exposure to C. sakazakii induced apoptosis and increased the
production of interleukin-6 in IEC-6 cells and in the animal model (Hunter et al. 2008). The
data generated from this research suggests that C. sakazakii could be a potential pathogen that
induces NEC, and triggers intestinal disease by modulating enterocyte intracellular signaling
pathways.

Richardson et al. (2009) used neonatal mice as models for C. sakazakii infection in infants.
The objective of the study was to compare the susceptibilities of to C. sakazakii strain MNW2.
Newborn miee of three different strains (BALB/c, C57BL/6, and CD-I mice) were infected
with different size dose ranging from approximately 10" to 10

CPU of C. sakazakii strain

MNW2 on postnatal day 3.5 in reconstituted PIF (Richardson et al. 2009). The mice were
observed for morbidity and mortality. Remaining pups had to be euthanized at postnatal day
10.5. Brain, liver, and cecum were then excised and analysed for the presence of C. sakazakii.
C. sakazakii was isolated from the brains, livers, and ceca in all three of the mouse strains
(Richardson et al. 2009). The CD-I mouse strain was the most susceptible of the three, with
the lowest infectious dose (10 CPU) and the lowest lethal dose (also 10 CPU) (Richardson et
al. 2009).

Subsequently, in 2010 the same group of scientists undertook another study, the objective
was to compare the virulence of three strains of C. sakazakii in neonatal CD-I mice. On PND
10.5, C. sakazakii was isolated from all three tissues in mice treated with C. sakazakii,
regardless of strain (Richardson et al. 2010). The results from the study found that the
invasiveness of C. sakazakii does not necessarily correlate with mortality among different
strains of C. sakazakii, and the clinical isolates are more virulent than the food isolate
(Richardson et al. 2010). It is the first study to date to find that different isolates of C.

10

sakazakii are more virulent than others, and it is not surprising to learn the clinical isolates are
more virulent than the food isolates.

Another study in 2010, was carried out by Hyun-A et al. (2010) to evaluate the usability of
neonatal ICR mice as an animal model for C. sakazakii infections in premature infants. The
team observed C. sakazakii infection-related deaths in infected neonatal mice. As well as C.
sakazakii isolated from liver, brain, and cecum of infected survival mice. In the C. sakazakii
infected mice, histopathological changes were detected in brain, liver and cecum (Hyun-A et
al. 2010). Figure 3 shows a magnification of the cerebrum of mice that were infected with C.
sakazakii. In Figure 3 (A) it can clearly be seen that gliosis is causing clumping, while in
Figure 3 (B) the effects of meningitis can be seen around the outer layer. These findings are
further proof of the effects C. sakazakii has on the host.

-if

Figure 3. Histopathological findings of the cerebrum of C. sakazakii-miQQXQd mice. (A)
gliosis (black arrows),bar=100 pm. (B) meningitis (black arrows), bar=50 pm. (Hyun-A et al.
2010)

The results indicated that C sakazakii could be colonized and replicate in ICR mice, as well
as inducing meningitis and gliosis in neonatal mice (Hyun-A et al. 2010). These findings were
important because meningitis and other neurological conditions are known to occur in human
infants because of C. sakazakii infection. The study by (Hyun-A et al. 2010) confirmed that

neonatal ICR mice can be a very effective animal model for human neonatal C. sakazakii
infections.

Infants who recover from infection may have morbidities such as hydrocephalus, mental
retardation, or developmental delays. Although increasing age appeared to reduce
susceptibility to Cronobacter infection, it is not known at what age or why these infants
become less susceptible (Richardson et al. 2012). Recent research by Richardson et al. (2012)
compared the susceptibilities of neonatal mice of different ages to C. sakazakii infection.
Neonatal mice were orally given a single dose of vehicle or 10^, 10^, or 10*^ CFU/ml C
sakazakii strain MNW2 in reconstituted PIF at postnatal days (PNDs) 1.5, 5.5, and 9.5. Brains,
livers, and ceca were excised and analysed for C. sakazakii invasion, and blood was collected
for serum amyloid A analysis as a biomarker of infection.

The results found that C. sakazakii invasion was age dependent. C. sakazakii was isolated
from brains, livers, and ceca of neonatal mice treated at PNDs 1.5 and 5.5 but not from those
of pups treated at post natal day 9.5. C sakazakii was more invasive at PND 1.5 in brains than
in livers and ceca and was isolated from 22, 14, and 18% of these tissue samples, respectively
(Richardson et al. 2012). Serum amyloid A was detected in only one treated neonate, and
mortality was observed only in neonates treated at PND 1.5 (Richardson et al. 2012). The
study has shown that neonatal mice have a time-dependent susceptibility to C. sakazakii
infection. The resistance to C sakazakii increased with increasing age (Richardson et al.
2012). The results from the study are not that surprising to us as they agree with the high
mortality rates for infected neonates of 50-80%. The neonates are more susceptible to C.
sakazakii because of their low resistance due to young age.

1.4.4 Studies with Human Cell Lines

Mange et al. (2006) carried out a study into the adhesive properties of Cronobacter
sakazakii to human epithelial and brain microvascular endothelial cells. The study was the
first to provide data on the adherence ability in C. sakazakii strains. The study investigated the

12

potential of C. sakazakii strains from various origins to adhere to HEp-2 and Caco-2 cells, two
well established and frequently used in-vitro models for studying interactions of bacteria with
human cells. Similar to Citrobacter diversus or Citrobacter freundii, C. sakazakii appears to
have a tropism for the central nervous system, which relates to the organism's ability to breach
the blood-brain barrier (Kline et al. 1988, Badger et al. 1999, Burdette et al. 2000). The study
investigated the adherence ability of 50 C. sakazakii strains to the two epithelial cell lines
HEp-2 and Caco-2, as well as the brain microvascular endothelial cell line HBMEC. To add to
the investigation, the effects of bacterial culture conditions on the adherence behaviour were
included and an attempt was made to characterize the factors involved in adherence of C.
sakazakii to mammalian cells.

The results were that two distinctive adherence patterns, a diffuse adhesion and the
formation of localized clusters of bacteria on the cell surface could be distinguished on all
three cell lines. The two distinct patterns are shown below in Figure 4 . In some strains, a
mixture of both patterns was observed. Adherence was maximal during late exponential phase,
and increased with higher MOl. The adhesion capacity of C. sakazakii to HBMEC cells was
affected by the addition of blood to the bacteria growth medium.

I li

A

I

B

Figure 4. (A) Light micrograph of C. sakazakii strain ES3 adhering in clusters. (B) strain ES6
showing diffuse adherence to HEp-2 cells. (Mange et al. 2006)
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Mannose, hemagglutination, trypsin digestion experiments and transmission electron
microscopy suggested that the adhesion of C sakazakii to the epithelial and endothelial cells
is mainly non-fimbrial based. Adherence experiments show heterogeneity within different C
sakazakii strains. In agreement with studies on E. cloacae, no relationship between the
adhesive capacities in C. sakazakii and the eventual production of specific fimbriae was found
(Mange et al. 2006).

The mechanisms that C. sakazakii uses to invade and translocate through the intestinal
barrier are unknown. However using Caco-2 epithelial cells (Kim et al. 2008), scientists were
able to demonstrate penetration of C. sakazakii and determine invasion-associated properties.
They found that C. sakazakii entry and invasion was dependent on the exposure time and
multiplicity of infection and required bacterial de novo protein synthesis but was independent
of cell polarity in the presence of tight junctions. Moreover, the presence of actin filaments
and microtubule structures was required, and disruption of the tight junction significantly
enhanced the initial association with Caco-2 cells and the efficiency of invasion, which
provides a possible explanation for the preferential occurrence of this infection in babies and
neonates (Kim et al. 2008).

To examine C. sakazakii infection, human studies have not been allowed as they are
unethical, as mortality is a possible outcome for suitable individuals. Therefore, animal
sun'ogate studies such as the studies discussed in this section have been essential for the
extrapolation of C. sakazakii infections in humans. The design of animal models for C.
sakazakii infection is fundamental in gaining an insight and greater knowledge into why
immunocompromised and premature human infants are at a greater risk of infection. Such
animal models will allow scientists in the near future to test different strains of C. sakazakii
for virulence.

In the recent future, it would be ideal if studies were carried out in order to determine the
adhesin(s) proteins that are involved in the interaction of C. sakazakii with cells and to
enhance knowledge of the pathogenesis of C. sakazakii infection, and part of the aim of this
study on the protein-protein interactions between C. sakazakii and a human host is just that.
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1.5 Control and Prevention Strategies
Urmenyi and Franklin, reported the first two known cases of terminal neonatal meningitis
implicating an at>T3ical ‘yellow pigmented Enterobacter cloacae' (Urmenyi et al. 1961). Since
then, there have been at least 111 reported accounts of this severe infection in infants and
children, including 26 deaths worldwide (Nazarowee-White and Farber 1997a, Iversen and
Forsythe 2003, Gurtler et al. 2005, Drudy et al. 2006, Mullane et al. 2008). Voluntary recalls
of PIF contaminated with Cronohacter have occurred in the United States, Europe and AsiaPacific region, which in turn, resulted in a collective effort between health-care facilities,
governing bodies and manufacturers in order to improve hygienic practices and ensure that
higher microbiological standards are maintained. To reduce the health risks associated with
the use of PIF, food and clinical professionals need to be continually updated regarding the
current status of strains from the Cronohacter genus, including reservoirs of contamination,
methods of detection, ecology, virulence characteristics and risk management strategies.

Controlling the organism in the production environment, thereby reducing dissemination,
would necessitate the provision of various suitable diagnostic tools. NEC remains the most
common gastrointestinal surgical emergency in these infants. The International Commission
on Microbiological Specifications for Foods has ranked Cronohacter as a "severe hazard for
restricted populations"(Baldwin et al. 2009). Because of its resistance to certain antibiotics, a
better understanding of the pathogenesis of this organism is needed to aid in the development
of new preventive strategies.

In a study of 125 infants with NEC, Cronohacter were found to be the most common
bacterial isolates, being recovered from 29% of the patients (Chan K., et al. 1994). Different
studies have demonstrated that a high degree of variability exists within the phenotypic-based
methods used to identify C. sakazakii. Although, there have been some advances in molecular
detection and subtyping techniques which have significantly improved the identification and
characterisation of C sakazakii. Figure 5, shows a rat intestinal cell with C. sakazakii
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adhering to the host intestinal rat cell.

X2VOO

Figure 5. Transmission electron micrograph of rat intestinal epithelial cell (IEC-6) with
adherent C. sakazakii (arrow). (Hunter et al. 2008)

C sakazakii is resistant to routine sterilization methods. It is fairly resistant to osmotic, heat,
and dry stresses, which may explain its presence and survival in desiccated infant powder and
similarly prepared products (Nazarowec-White et al. 1997, Breeuwer R, et al. 2003). In fact,
Nazarowec-White and Farber found that C. sakazakii was the most thennotolerant among the
Enterobacteriaceae (Nazarowec-White et al. 1997). Although the optimum temperature for C.
sakazakii growth is 39°C, it is reported to grow at less than 4°C, suggesting the species would
be able to replicate even during refrigeration (Iverson et al. 2004). Which is a major concern
as this is not the usual for most bacteria and usually refrigeration at such temperatures does
not allow bacteria to replicate. Additionally, it produces a yellow pigment that may protect the
cells against UV rays and also has the ability to form capsules and fimbriae that enable the
organism to adhere to different surfaces (Mullane et al. 2006). These physiological
characteristics not only enhance survival in the food production environment, but may also
contribute to persistence in other environmental sources such as water, soil, and vegetables.
It has been suggested that C. sakazakii may form biofilms therefore making it resistant to
disinfectants. C. sakazakii is able to survive in powder for at least 12 months. The actual
amount of Cronobacter contamination usually is low, ranging from 0.36 to 66 colony-forming
units (CFU)/100 g (Muytjens et al. 1988). Although, in dry environmental samples from
infant formula factories, a 40% prevalence rate has been reported. As a result of the

16

widespread prevalence of C. sakazakii in many various food products and the risks that are
associated with it, reference detection methods have been established to quantify C. sakazakii
in food products (Guillaume-Gentil et al. 2005, Iversen et al. 2006).

Improper storage and temperature regulation may lead to an increase in the bacterial load
and therefore facilitating outbreaks of infection. Although C. sakazakii infection may arise
secondary to poor storage and reheating of infant formula, it has not been proved definitively
that hospital staff themselves are not a vector for C. sakazakii. Unfortunately, hospital
personnel may ignore appropriate hygiene practices, and thus may contribute to the spread of
infection (Gould et al. 2010). Therefore, it is obvious that great care should be taken in
adhering to strict hand washing and contact isolation of affected and susceptible infants.
.Although this practice of strict hygiene should be followed routinely in all hospitals, by all
personnel, in some cases it is not. It is difficult to supervise all personnel while they wash
their hands to ensure that they are doing it properly, therefore all personnel must take it upon
themselves to ensure that a greater level of attention and thoroughness is followed when it
comes to hand washing as well as contact with the infants.

The ability of potential probiotic strains to adhere to the intestinal mucosa and exclude and
displace pathogens is of utmost importance for therapeutic manipulation of the enteric
microbiota. In 2005, Collado and Gueimonde tested the ability of different bifidobacteria to
inhibit different pathogen adhesion and to displace pathogens previously adhering to cells in a
human intestinal mucus model. The ability of seven selected human bifidobacterial strains and
five human enteropathogenic strains (including C. sakazakii ATCC 29544) to adhere to
human intestinal mucus was analysed and compared with that of four strains which were
isolated from chicken intestines.

The adhesion of the bifidobacterial strains ranged from 3 to 16% depending on the strain.
Bifidobacterium strains of animal origin adhered signifieantly better than did strains of human
origin. Collado et al. (2005) showed that in general bifidobacterial strains of animal origin
were better able to inhibit and displace pathogens than were human strains. The results from
this study indicate that different molecules are implicated in the adhesion of bifidobacteria to
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the human intestinal mucus, constituting a multifactorial process. This study showed that the
C. sakazakii type strain ATCC 29544 had adhesion values ranging from 10 to 15% (Collado et
al. 2005). These results indicate that C. sakazakii ATCC 29544 had a stronger adhesive
potential than Listeria did and a slightly weaker adherence potential compared to E. coli,
which had the highest adhesive value.

When it comes to the treatment of C sakazakii infections, in most infants that are infected
with C. sakazakii, as well as having sepsis or meningitis, seizure activity has been reported in
nearly 30% of those affected. After initial resuscitation and prompt administration of
antibiotics, a head computed tomography scan should be considered strongly. These
recommendations should be extended to adult patients, especially those who are
immunocompromised, and have C sakazakii positive cultures (Hunter et al. 2008).
Intracranial findings that have been described in association with C sakazakii, although not
exclusive to patients with C sakazakii meningitis, include abscess fomiation, ventricle
dilation, infarcts, and hydrocephalus (Burdette et al. 2000). C sakazakii infection typically
has been treated with ampicillin and gentamicin. However, many Cronohacter species are
resistant to narrow-spectrum penicillins that traditionally have good activity against
Enterohacteriaceae such as E. coli (i.e. ampicillin and amoxicillin). It has been pointed out
that increasing resistance of C. sakazakii to antibiotics should prompt physicians to consider
carbapenems

(i.e.

imipenem-cilastatin,

meropenem,

or

ertapenem)

or

the

newer

cephalosporins (e.g. cefepime) in concert with a second agent such as an aminoglycoside (Lai
et al. 2001).

Regarding prevention strategies and Cronohacter infections, a variety of strategies have
been suggested to minimize the risk of C sakazakii contamination of infant formula,
including the use of gamma radiation and C.

-targeted bacteriophage therapy to

reduce bacterial growth (Lee et al. 2006, Kim et al. 2007). However, there are much simpler
strategies that exist which may be just as effective, such as the promotion of breast milk
feeding, as oppose to using (PIF) because it is known to be the main form of transmission of
C. sakazakii, as well as the inclusion of warnings on packages of powdered infant formula
that they may be contaminated with C sakazakii and discouraging people from pre-warming

the reconstituted formula. In adults, despite a lack of definitive source identification, it would
be prudent to limit the use of reconstituted dairy products in immunosuppressed populations.
In hospitals, further encouragement and incentives for health care providers to use universal
precautions should be mandated, and the “hang time” of enteral feeding solutions should be
minimized (Hunter et al. 2008).

Commercially available biochemical identification kits have been routinely employed in
food and clinical microbiology to identify bacteria from a wide variety of sources. Although
the accuracy and reliability of these tests were questioned lately, with reports that some
resulted in false negative and -positive identifications (Restaino et al. 2006, Iversen et al.
2007). Recently, a company called Biolog (located in Hayward, California), have developed
Gen III Identification plates, used for the identification of either Gram-negative or
Gram-positive organisms. Currently they are the only commercially available biochemical
identification kits to include the updated taxonomy of the Cnmohacter genus, with all six
genomospecies being identified (Healy, unpublished data).

In 2010, scientists at University College Cork developed a bioluminescence based approach
for the real-time monitoring of C. sakazcikii in reconstituted PIF (Morrissey et al.2010).
Figure 6 shows some of the results.
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Figure 6. (A) Growth of lux-tagged (black squares) and non-tagged (white circles) C.
sakazakii strains in LB broth. (Morrissey et al. 2010).

A study using human and environmental isolates of C. sakazakii carried out in 2012, found
that human isolates of C sakazakii bind to rat and human enterocytes more efficiently than
environmental strains (Liu et al. 2012). Human isolates also caused tight junction disruption
and significant apoptosis of enterocytes compared with environmental strains due to increased
production of inducible nitric oxide (Liu et al. 2012) . The study also found that human C
sakazakii isolates caused 2-fold increase in the activation of phosphokinase C (PKC) than
environmental strains (Liu et al. 2012). Blocking the PKC activity in enterocytes by an
inhibitor, Go 6983, suppressed C. ^r/te^zAiz-mediated tight junction disruption, monolayer
permeability, and apoptosis of the cells, these results suggest that human isolates of C.
sakazakii more efficiently bind to and cause damage to intestinal epithelial cells compared to
environmental strains (Liu et al. 2012).

The fact that this group of scientists have shown that blocking PKC activity with an
inhibitor 'Go 6983' (Liu et al. 2012), suppresses C. 5aA<3z<r/A7/-mediated tight junction
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disruption, monolayer permeability as well as apoptosis of the cells, is a sizable finding in this
area of research as this hasn't been demonstrated before with C. sakazakii. It shows that
inhibitors can work on suppressing the effects of C. sakazakii such as apoptosis of host cells.

1.6 Cronobacter Genome Sequencing and Analysis of Strains
1.6.1 The Cronobacter sakazakii BAA-894 Genome

The first genome sequence of a member of the Cronobacter genus, C. sakazakii strain
BAA-894 was completely sequenced by Kucerova et al. (2010). The genome of Cronobacter
sakazakii strain BAA-894 consists of a 4.4 Mb chromosome (57% GC content). It has two
plasmids. Both have been completely sequenced. The first plasmid, pESA2 is 31 kb (51% GC)
and 31208 bp circular DNA, and the second plasmid pESA3 is 131 kb (56% GC) and 131196
bp circular DNA. Thirty-eight genes were annotated on pESA2 and 127 genes on pESA3
(Kucerova et al. 2010). The ratio was (1:1.1:8.6) for the chromosome versus pESA2 versus
pESA3, showing that pESA2 exists as low copy, and pESA3 appears to be a moderate copy
number plasmid (Kucerova et al. 2010). The genes on pESA2 were absent in all other strains
tested except C. turicensis, which had 19 (61.3%) genes present, and C. sakazakii 696, which
had 4 (12.9%) genes present.

Within the 4,382 annotated genes inspected in the study, it was found that about 55% of
genes were common to all of the 11 strains of C. sakazakii used in the study, while 43% were
common to all Cronobacter strains, with 10-17% absence of genes (Kucerova et al. 2010).
Comparative Genomic Hybridization (CGH) highlighted 15 clusters of genes in C. sakazakii
BAA-894 that were divergent or absent in over half the strains tested. Six of these are of
probable prophage origin (Kucerova et al. 2010).

The study by Kucerova et al. (2010) has provided invaluable information on C sakazakii
that was previously unknown due to the fact that no species from the Cronobacter genus had
its genome completely sequenced before this. The study demonstrates the advantages of
genome sequencing. The unique genes identified in the study included a copper/silver
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resistance resistance cluster associated with invasion of BMEC, which were unique to the
thi'ee Cwnohacter species associated with neonatal infections, as well as efflux pumps and
adhesins unique to C. sakazakii strains from NICU outbreaks. Therefore, this copper and
silver resistance system could be one of the mechanism's that enable C. sakazakii to cross the
blood brain barrier. In addition, genes encoding for multidrug efflux pumps and adhesions
were identified that are unique to C. sakazakii strains obtained from outbreaks in various
neonatal intensive care units (Kucerova et al. 2010).

The study also revealed that gene acquisition through integration of phages and other
mobile elements and specific gene loss play a major role in the evolution and diversity of the
Cronohacter genus. Fifteen clusters of genes including three putative prophages and three
putative prophage fragments that were absent in more than half tested strains were identified,
in most of them, putative virulence genes were identified (Kucerova et al. 2010). Future
studies should focus on the expression of virulence related genes and their role in the
pathogenicity of Cronohacter species, particularly the mechanisms of neonatal infection. It is
evident that the increasing availability of genome sequences in this genus are helping to
identify C. sakazakii proteins that are involved in the interaction of C sakazakii with the
human host.

1.6.2 Comparative Genomic Indexing (CGI) of Cronohacter sakazakii BAA-894

To further enhance our understanding of the genetic relationship between C. sakazakii
BAA-894 and the other species of this genus, another study (Healy et al. 2009), used
microarray-based comparative genomic indexing (CGI) to determine the presence or absence
of genes identified in the sequenced genome and compare 276 selected open reading frames
within the different Cronohacter strains. Seventy-eight Cronohacter strains (60 C sakazakii),
representing clinical and environmental isolates from various geographical locations were
used. Hierarchical clustering of the CGI data showed that the species grouped as clusters, the
5 C. duhlinensis and 2 C. muytjensii strains examined formed distinct species clusters, all of
the C. sakazakii and 3 of 8 C. malonaticus strains formed a large cluster (Healy et al. 2009).
The remaining C. malonaticus strains formed a sub-group within a larger cluster that also
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contained C tiiricensis, C. genomospecies 1, and an unknown Cronobacter sp. C. sakazakii
and 3 of 8 C. malonaticus strains could be distinguished from the others within the collection
by the presence of 10 fimbrial related genes, while capsule and/or lipopolysaecharide (LPS)
related glycosyltransferases differentiated several of the C. sakazakii strains from each other
(Healy et al. 2009). This is interesting as LPS is already thought to play a role in the virulence
of C sakazakii as discussed previously.

1.6,3 Other Cronobacter Species Studies

The sequencing of closely related Cronobacter strains in the near future will further will
pave the way for greater the research into this genus. Stephan et al. (2011) completely
sequenced the genome of the closely related C tiiricensis LMG 23827. C. tiiricensis LMG
23827, is a strain that caused the deaths of two newborn children in a children’s hospital in
Zurich in 2005, and was the chosen strain to sequence and annotate the genome of a
representative and evidently pathogenic member of the genus Cronobacter.

The genome of C tiiricensis consists of a circular chromosome with a size of 4,384,526 bp
and three plasmids with sizes of 138,339 bp, 22,448 bp, and 53,842 bp. Altogether, 4,455
coding sequences were identified, of which 9.27% did not show similarities to other proteins
in public sequence databases and therefore remain unknown proteins. The genome encodes 84
tRNAs with 40 different codons for 21 amino acids, including selenocysteine. Seven rRNA
operons were found in the genome, which is comparable to many other Enterobacteriaceae.
The remarkable number of 122 coding sequences have been predicted as putative
pseudogenes. Almost 95% of these probably un-transcribed genes retained detectable
homology to annotated genes in other organisms, allowing investigation into which particular
functions are putative targets of gene degradation (Stephan et al. 2011).

In 2009, the complete proteome of Cronobacter tiiricensis 3032, which caused two deaths
the same year, was fully mapped with the aim of gaining a better understanding of the
physiology and putative pathogenic traits of the C. tiiricensis 3032 clinical isolate (Carranza
et al. 2009). Analysis of extracellular, surface-associated and whole-cell proteins using two
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complementary proteomics approaches, lead to 832 proteins being identified which
remarkably corresponded to 19% of the theoretically expressed protein complements of C
turicensis. Most of the proteins that were identified are involved in central metabolic
pathways, protein folding and stability as well as translation. Several putative virulence
factors, were confirmed by phenotypic assays, and therefore were identified: a macrophage
infectivity potentiator involved in C. turicensis persistence in host cells, a superoxide
dismutase

which protects

the pathogen

against

reactive oxygen

species

and an

enterobactin-receptor protein for the uptake of siderophore-bound iron (Carranza et al. 2009).

Franco et al. (2011), investigated putative virulence genes on the Related RepFIB Plasmids
harbored by Cronohacter. Whole-genome sequencing of C. sakazakii BAA-894 and C
turicensis z3032 revealed that they harbor similarly sized plasmids identified as pESA3 (131
kb) and pCTU 1(138 kb), respectively. In silica analysis revealed that both plasmids encode a
single RepFIB-like origin of replication gene, repA, as well as two iron acquisition systems
{eitCBAD and iucABCD/iutA) (Franco et al. (2011).

The plasmid pESA3 contains a cpci gene {Cronohacter plasminogen activator) and a 17-kb
type 6 secretion system (T6SS) locus, while pCTUl contains a 27-kb region encoding a
filamentous hemagglutinin gene {fhaB), its specifc transporter gene ifliaC), and associated
putative adhesins (FHA locus), suggesting that these are virulence plasmids (Franco et al.
2011). In a rqpzl-targeted PCR assay, 97% of 229 Cronohacter species isolates were found to
possess a homologous RepFIB plasmid, while all repA PCR-positive strains were also positive
for the eitCBAD and iucABCD/iutA iron acquisition systems (Franco et al. 2011).
The study has provided an insight into the functionality of the iuc siderophore acquisition
system encoded on the pESA3 and pCTU 1 plasmids. The authors found that together, these
properties may contribute to the systemic survival of C. sakazakii and the inevitable invasion
of the central nervous system to cause disease. They demonstrated that pESA3 and pCTUl
encode active siderophores, and in silica analysis showed that the two plasmids encode other
potential virulence factors, such as Cpa, a T6SS, and a filamentous hemagglutinin (Franco et
al. 2011). The study has also revealed that most Cronohacter species strains harbor a
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homologous RepFIB-like plasmid, and has also shown a strong correlation between the
RepFIB-likeplasmid type, or “plasmidotype,” with specific Cronohacter spp. (Franco et al.
2011). This suggests that these nonmobile plasmids were acquired long ago and have
coevolved with each of the different species in a fashion similar to their chromosomal
genomes. Furthermore, the authors results support the hypothesis that these plasmids have
evolved from a single archetypical plasmid backbone through the deletion, or cointegration,
of specific virulence traits in each species (Franco et al. 2011).
integrase
cpa
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iuc parAB repA
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integrase

Figure 7. Sequence alignment of pESA3 and pCTU 1, produced with the Artemis Comparison
Tool (ACT). A schematic of each plasmid is shown above (or below) its corresponding ruler.
Select genes or loci are shown in color as follows: eit (red), iuc (orange), parAB and repA
(purple), integrase (black) and associated genes (white), cpa (teal), T6SS (blue), and FHA
(brown). In the middle section, the red color indicates significant nucleotide homology, as
determined by BLASTN analysis, between pESA3 and pCTUl, and the location on each
plasmid, for example eit, iuc, parAB, and repA. White indicates regions or loci present on one
plasmid and absent on the other, e.g., cpa, T6SS, and FHA. (Franco et al. 2011).
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1.7 Conclusion
This literature review has summarized C sakazakii's bacterial characteristics, details of
outbreaks/infections and the disease it causes in infants and the elderly, as well as the
virulence factors and interaction with the host. Additionally the paper has reviewed pathogen
genome sequencing projects and given an example of when in silico analysis has provided
information on the virulence of a pathogen such as C. sakazakii.

At present, little is known about the mechanisms used by C. sakazakii to interact with a
human host and cause disease. It is highly probable that some of these mechanisms are similar
to those used by other closely related gastrointestinal pathogens such as adhesin proteins to
attach to other epithelial cells and invasion proteins to get inside of the host cell.

Following on from this review, the subsequent project aims to predict the proteins involved
in the interaction between C. sakazakii. The data generated, will have the potential to provide
important clues about proteins important for the pathogenesis of C. sakazakii. And in turn, the
proteins identified could be the focus of future research into potential therapeutics and
antimicrobials against C sakazakii.
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2. Materials and Methods
2.1 Relatedness of C. sakazakii to Other Enterobacteriae Family Members
In order to detemiine the relatedness of C. sakazakii to other Enterobacteriaceae members,
the following two approaches were used: 1. Phylogenetic analysis 2. Pairwise Sequence
Comparison.

2.1.1 Phvlo2enetic Analysis

For the phylogenetic analysis, a phylogenetic tree was created. A total of 16 bacterial
sequences were used. The sequences used were 16S rRNA gene sequences, and were found in
the Ribosomal Database Project (RDP) (http://rdp.cme.msu.edu/). The strains used are listed
in (Table 1).

Table 1: 16S rRNA gene sequences used.
Bacterial 16S rRNA

Ribosomal

Sequence

Project (Accession #)

Cronohacter sakazakii

S000453737

Database

GenBank
(Accession #)

AY752937

ATCC 51329
Cronohacter sakazakii zES4

S000455859

AY803186

Cronohacter sakazakii JCM1233 S000381741

AB004746

Cronohacter muytijensi E456

S000842664

EF059837

Cronohacter diihlinensis (T)

S000842665

EF059838

E464
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Cronobacter turicensis E609
Cwnobacter condimenti

S000842675
S001610324

EF059848
FN539031

1330;
type strain 040407/32
Cwnobacter malonaticus (T)

S000842708

EF059881

S000926442

EU014682

S000640788

DQ344533

Klebsiella oxytoca

S000006238

Y17667

Enterobacter aerogenes

S000009798

AF395913

Enterobacter asburiae (T)

S000381739

AB004744

Raoiiltella terrigena

S000406024

Escherichia coli

S000389727

Citrobacter freiindii

S000406024

E825
Salmonella Bongori DSM
13772
Salmonella enterica subsp.
enterica serovar Typhimurium

AY292874
AF233451
AY292874

A multiple sequence alignment had to be carried out in order to create the phylogenetic tree.
The multiple sequence alignment was created with Clustal Omega, which was accessed
through (http://www.ebi.ac.uk/Tools/msa/clustalo/). Once the multiple sequence alignment
was complete, a phylogenetic tree was constructed using MEGA 5.1 (Molecular Evolutionary
Genetics Analysis) program which was downloaded from (http://www.megasoftware.net/).
1000 bootstrap replicates were carried out to show the bootstrap figures. The purpose of
bootstrap analysis is to find out the probability of a branch existing on the true tree. The
higher the bootstrap value, the higher the probability.

2.1.2 Pairwise Sequence Comparison

The Artemis Comparison Tool (ACT), was the chosen tool for the pairwise comparison
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between C sakazakii (NC_009778) and Salmonella hongori (NC_015761). The complete
genome sequences used can be found in the National Centre for Biotechnology Information
(NCBI) nucleotide database. Filter levels of 0 and 100 were the two levels of stringency used
for the BLASTN to create the ACT alignment of the C. sakazakii and Salmonella hongori
genomes.

2.2 Predicting Putative Virulence Factors in the C. sakazakii BAA-894
Genome
2.2.1 Identifying Homolo2ues oiSalmonella Virulence Factors

Due to the fact that Salmonella is closely related to C. sakazakii, it was the bacteria of
choice for comparison with C. sakazakii. Salmonella virulence factors that are required for
interaction with the human host intestine were selected from published literature as well as the
Virulence

Factor

Database

(VFDB)

(http://www.mgc.ac.cn/VFs/).

Individual

protein

sequences were found in the NCBI protein database. Homologous proteins were identified by
carrying out BLAST? searches against the C. sakazakii genome directly. Various parameters
were used for the BLASTP searches, such as an E-value cutoff of lower than le-5, percent
identity greater than 25% and a percent coverage greater than 70% in order to be called a
homologue.

2.2.2 Predicting Putative Virulence Factors in C sakazakii

Secondly, the C. sakazakii genome was searched for homologues of the potential C.
turieensis virulence proteins that Carranza et al. (2009) identified. If significant hits are
produced then it can be said that the C sakazakii protein most likely has the same function.
These proteins may be involved in numerous biological processes such as secretion and
transport systems, iron or copper acquisition and the protection against reactive oxygen
radicals.
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2.2.3 Analyzing the Subceiluiar Location

The subceiluiar location of the selected proteins was predicted using the PSORT program
(http://psort.hgc.jp/).

2.2.4 Determining Transmembrane Reeions

Transmembrane regions were also predicted for selected proteins using a program called
TMHMM (http://cbs.dtu.dk/services/TMHMM/).

2.2.5 Identifying Conserved Domains

The proteins were analysed further for the presence of conserved domains using the NCBI
conserved domains search tool.

2.3 Identifying Putative Fimbrial Adhesins in the C sakazakii BAA-894
Genome
2.3.1 NCBI Keyword Search Tool

Using the keyword search tool on the NCBI C. sakazakii genome page, the C. sakazakii
genome was searched for potential virulence proteins. Keywords used were “fimbrial”,
“adhesion” and “adhesion”. The keyword search is performed by holding the 'CTRL' and 'F'
keys on the keyboard simultaneously, a search abr pops up at the bottom of the page and you
type in the keyword you wish to use and if found in the genome it displays it.

2.3.2 C. sakazakii Homologues of Salmonella Fimbrial Proteins

Using BLAST, Salmonella and E. coli fimbrial proteins were searched against the whole C.
sakazakii genome. The Salmonella and E. coli Fim proteins were identified in the VFDB. The
sequences were obtained from the NCBI protein database.
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2.3.3. C sakazakii Homologues of E. coli Fimbrial Proteins

Using BLAST, Salmonella and E. coli fimbrial proteins were searched against the whole C.
sakazakii genome. The Salmonella and E. coli fimbrial proteins were identified in the VFDB.
The sequences were obtained from the NCBI protein database.

2.4 Comparative Modelling of Putative C. sakazakii Fimbrial Proteins
Using the predicted putative FimH proteins it was decided to create a 3D model of the
proteins through comparative modelling. The proteins modelled were ESA_01973,
ESA_02342, ESA_02539, ESA_02541 and ESA_04070.

2.4.1 Identifying Conserved Domains

The putative FimH proteins were analysed for conserved domains using the NCBI
conserved domain search tool. The subcellular location of the proteins was also predicted
using PSORT and Signal? (http://www.cbs.dtu.dlc/services/SignalP/).

2.4.2 Model Building

The traditional method to comparative modelling, which can be more accurate but also time
consuming consists of four consecutive steps. The first step is fold assignment and template
selection. Which involves carrying out a BLAST to find homologous structures. The second
step involves template-target alignment, involving a multiple alignment of the homologous
sequences, the third step is the building of the model itself and the fourth and final step is
model evaluation. This is repeated iteratively until a worthy model is generated.

The approach used for this part of the study involved submitting the complete protein
sequences of the putative C. sakazakii FimH proteins to three modelling servers. The three
servers are unique and automatically carry out the first few steps in the traditional modelling
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process for you i.e. searching databases for homologues, creating a multiple alignment and
building the predicted structure of the query sequence by comparing it to a protein that has an
experimentally resolved structure and is homologous to the protein submitted, as an ideal
template. Multiple proteins can be ideal templates.
The first server used in the modelling of the putative C. sakazcikii FimH proteins was
Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). The Phyre2 (Protein
Homology/analogY Recognition Engine V 2.0) Webserver was designed and written by Dr.
Lawrence Kelley. Phyre2 is the successor to the two web servers he previously developed,
3D-pssm and Phyre. Phyre2 has been ranked amongst the best systems of its kind for the last
four years as judged by the biannual Critical Assessment of Structure Prediction (CASP)
meetings. The work on developing the Phyre2 web server is supported by a BBSRC tools and
resources grant.

The second was the SWISS-MODEL sever (http://swissmodel.expasy.org/). It is a fully
automated protein structure homology-modelling sei*ver, accessible via the ExPASy web
server, or from the program Deep View (Swiss Pdb-Viewer). The purpose of this server is to
make protein modelling accessible to all biochemists and molecular biologists worldwide.

The

third

server

used

for

modelling

(http://zhanglab.ccmb.med.umich.edu/l-TASSER/)

for

was
protein

the

1-TASSER

structure

and

server
function

predictions. With this server 3D models are built based on multiple-threading alignments by
LOMETS and iterative TASSER assembly simulations; function insights are then derived by
matching the predicted models with BioLiP protein function database. The server is in active
development with the goal to provide the most accurate structural and function predictions
using state-of-the-art algorithms. Each protein modelled was then submitted to EXPRESSO to
create a multiple sequence alignment of the protein with the templates used to model it.
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2.4.3 Model Evaiuation

Once the 3D shape of the target protein sequence had been predicted by the three servers,
the best ranked model of the three predicted was chosen. The models were sent to the
3DLigandSite server to identify binding sites in the proteins. A direct link was provided to
this site from the Phyre2 results generated for each C. sakazakii protein submitted to Phyre2.
The predicted models were further viewed and analysed using molecular visualization system
PyMOL, to completely visualize the predicted models in 3D. The models built were also
aligned with their templates using EXPRESSO, to identify any conserved residues.

2,5 Further Analysis of Putative C. sakazakii Fimbria! Proteins
2.5.1 Predicting Protein-Protein Interactions Usin2 STRING

The sequence of the FimH proteins modelled was by submitted to the STRING database for
further analysis.
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3. Results

3.1 Relatedness of C. sakazakii to Other Enterobacteriae Family Members
3.1.1 Phylogenetic Analysis

Cronohacter sakazakii

is

a

Gram

negative

opportunistic

pathogen

within

the

Enterobacteriaceae family. In order to determine how closely C. sakazakii was related to other
members of the Enterobacteriaceae family, two methods were used. The first was carrying out
phylogenetic analysis on the members. A phylogenetic tree was created which shows the
evolutionary relatedness of the Gram negative strains listed in (Table 1 in the Materials and
Methods). The phylogenetic tree (Figure 11), which was created by aligning 3 strains of C.
sakazakii with the other Cronohacter species, except for C. universalis, along with
Salmonella, Klebsiella, Enterohacter, Raoiiltella, E. coli and Citrohacter strains. Bootstrap
analysis shows values on each branch of the tree, these values represent the probability of the
branches existing on the 'true tree'. Unsurprisingly, the tree shows that all of the different
strains of Cronohacter are the most closely related. The next species most closely related to
any of the Cronohacter strains was the Escherichia coli strain. From the tree it can also be
seen that the two Salmonella strains were the third most closely related to any of the
Cronohacter strains.
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3G - - - - gil2209fl38|dlij|AB(lC474611 Enterobactef sakazakii gene for 16S nlxsoral partial s^iuerice
- - - - gi|118498844lgb|F()59881 1| Cronobacter malonatKiis strain E825 1SS nbcsorral RHA gene partial se<|uefK:e
- - - - - gi|5541623fl(gblAY8031(l611 Enterobacter sakazaki ^n iS416S ribosofal RI'IA gene patial serjuence
—gjl118498801^F088838 11 Crr^iobacter dublinensis subsp lactaridi stian E46i 16S nboscmal RNA gene paitid sequence
93- - - - gi!1184988111gblEF059848 11 Cronobacter turicensis stoi E6(I918S nboscrral RNA. gene partial sequence
- - - - - - gi^560940081emb|RI539031 11 Cronobacter condin«nti 1330 partid 16S rWlA gene t^’pe straki 1330
- - - - gil541247111gb|AY75293711 Enterobacter sakazaki strain ATCC 51S916S nbcscnal R7iA gene partial sequence
si- - - - gil1184988001gblEF059837 11 Cronobacter muytjensi stran E45fi 16S nbcsor^ RNA.gene partial sequence
- - - - - - g]71105811gb|AF23345111AF233451 Esctienchia coli 16S nbosoral RNA gene partial sequence
- - - - gl1567635631g()|EU014682 11 Salmonefla txmgon strain DSM 13772 168 nbcsorral RNA gene parb^ sequence
53- - - - gl855412251gb|[)Q34453311 Salmonella erkra subsp enterica sero^ar Tj^olrtfiurr 168 ribosomal RNA gene partial sequence
- - - - - - gl2209fl36|rlt)jAB(104744 1| Enterobacter asbunae gene for 168 nbosornal RflA partd sequence
- - - - - - gi|31697751gb(AF025365 11AF025365 Citrofcacter keundi 168 nbosomal RNA gene patial sequence
- - - - g|3282039|emb(Y17667 1| Klebsiella oxytoca 168 iRfiAgene strain i128-W partial
60- - - - g|31747563^Y2928741| Raoultella temgena isolate m 30 168 ntcscmal RflA gene partial sequence
- - - - - - g|15(l42704|gb|AF395913 1| Enterobacter aerogenes 168 nbosomal Rf lA. gene complete sequence

Figure 11. 16S rRNA gene phylogenetic tree of Cronobacter sakazakii (formally known as
Enterobacter, as referred to in the tree) along with other members of the Enterobacteriaceae
family. The tree was created using a distance based neighbour-joining method, combined with
a Felsenstein correction to infer the distance matrix. A bootstrap analysis was carried out 1000
replicates.

3.1.2 Pairwise Sequence Comparison

A pairwise alignment of the C. sakazakii BAA-894 and Salmonella bongori NCTC 12419
genomes was created (Figure 12.A and B respectively) using the Artemis Comparison Tool
(ACT). Salmonella bongori was chosen as it is closely related to C. sakazakii. The C
sakazakii BAA-894 genome encodes 4,257 proteins, has a GC content of 56% and has a
length of 4.3MB (megabases). While the S. bongori genome codes for 3,863 proteins, with a
GC content of 51% and a length of 4.4MB. The colored lines represent homology between the
two genomes. The red lines show forward homology, while the blue lines represent reverse
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homology. Over the whole genome of both species, a high similarity could be seen.
(A)
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Figure 12. The ACT pairwise alignment of C. sakazakii BAA-894 (top row) and Salmonella
bongori NCTC 12419 (bottom row) using BLASTN. (A) filter cutolf of 0 which shows every
match, (B) has a filter cutoff of 100 which is more stringent and shows only the stronger
matches.
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3.2 Prediction of Putative Virulence Factors in the C. sakaza/di Genome
3.2.1 Identifying of Homologues of Salmonella Virulence Factors
The Salmonella protein sequences were obtained from the NCBI protein database. C
sakazakii homologues of the Salmonella proteins were found by carrying out BLAST?
searches against the complete C sakazakii genome. Table 2 shows the best hits from the
BLAST? searches along with other information such as function, size, percent identity and
the E-value.

Of the 80 Salmonella virulence factors analysed, 29 homologues were identified in C.
sakazakii. The 29 homologous proteins are predicted to be involved in adhesion, secretion,
immune evasion, regulation, resistance, as well as one in magnesium uptake and one in stress.
The remaining 51 proteins for which no homologue could be found in C sakazakii included
some involved in adhesion, such as MisL, Agf, ShdA and RatB, however a few other adhesion
protein homologues were identified, such as ?efC and ?efD, SinH, Lpf and Fim proteins.
Others were proteins involved in immune evasion, secretion, antivirulence, magnesium uptake,
and some unclassified proteins.

Table 2. Salmonella virulence factors and their best BLAST hit against the C. sakazakii
BAA-894 genome. Further information on the functions of the Salmonella proteins can be
found in the appendix (Table 2.A).
Salmonella
Protein
(Accession #)

Function in
Salmonella

Best BLAST hit in
C sakazakii
(Accession #)

LpfA
(AAL22500.1)

Adhesion

LpfB
(AAL22499.1)

Adhesion

Hypothetical
protein
ESA 02538
(Y? 001438619.1)
Hypothetical
protein
ESA 02344
(Y? 001438429.1)
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Size of
Protein
(Amino
acids)
179

Percent
Identity
%

Percent
Coverage
%

E-value

34

97

7e-25

224

41

90

2e-55

LpfC
(AAL22498.1)

Adhesion

LpfD
(AAL22497.1)

Adhesion

LpfE
(AAL22496.1)

Adhesion

PefC
(AAL23521.1)

Adhesion

PetD
(AAL23520.1)

Adhesion

SinH
(AAL21411.1)

Adhesion

FimA
(CAD05025.1)

Adhesion

FimC
(AAL 19499.1)

Adhesion

FimD
(AA069911.1)

Adhesion

FimF
(AAL 19502.1)

Adhesion

FimH
(AAL19501.1)

Adhesion

Flypothetical
protein
ESA 01974
(YP 001438063.1)
Hypothetical
protein
ESA 02342
(YP 001438427.1)
Hypothetical
protein
ESA 02538
(YP 001438619.1)
Hypothetical
protein
ESA 01974
(YP 001438063.1)
Hypothetical
protein
ESA 02539
(YP 001438620.1)
Hypothetical
protein
ESA 00987(
YP 001437092.1)
Hypothetical
protein
ESA 02538
(YP 001438619.1)
Hypothetical
protein
ESA 02539
(YP 001438619.1)
Hypothetical
protein
ESA 01974
(YP 001438619.1)
Hypothetical
protein
ESA 02538
(YP 001438619.1)
Hypothetical
protein
ESA 02342
(YP 001438619)

38

795

44

94

0.0

342

31

100

4e-42

179

29

96

le-11

795

30

93

6e-74

223

35

95

5e-36

1027

36

71

2e-79

179

36

100

3e-22

223

40

87

le-45

795

43

93

0.0

179

32

100

le-13

342

30

55

5e-25

FimI
(AAL19498.1)

Adhesion

FimZ
(AAL19503.1)

Adhesion

TviB
(AA071805.1
)

Immune
Evasion

TviC
(AA071804.1
)

Immune
Evasion

VexB
(AA071800.1
)

Immune
Evasion

MgtB
(AAL22621.1)

Magnesium
uptake

Fur
(AAL19637.1)

Regulation

PhoP
(AAL20160.1)

Regulation

PhoQ
(AAL20159.1)

Regulation

RpoS
(AAL21804.1)

Regulation

Mig-14
(AAL21667.1)

Resistance
to
antimicrobi
al peptides

176

27

98

8e-13

218

28

98

2e-27

420

29

90

8e-47

337

29

92

3e-27

Hypothetical
protein
ESA 03359
(YP 001439416.1)
Hypothetical
protein
ESA_pESA3p0553
6
(YP 001440569.1)
Ferric
Uptake
Regulator
(YP 001438729.1)
DNA-binding
transcriptional
regulator PhoP
(YP 001438301.1)

258

26

80

3e-15

904

72

99

0.0

167

94

100

le-102

223

87

99

4e-145

Sensor
protein
PhoQ
(YP 001438302.1)
RNA polymerase
sigma factor RpoD
(YP 001436489.1)

501

77

97

0.0

614

42

87

le-62

Hypothetical
protein
ESA_pESA3p0543
9
(YP 001440472.1)

296

36

96

3e-61

Hypothetical
protein
ESA 01976
(YP 001438619.1)
Hypothetical
protein
ESA 01309
(YP 001438619.1)
UDP-N-acetylD-mannosamine
dehydrogenase
ESA 03771
(YP 001439799.1)
Hypothetical
protein
ESA 01535
(YP 001437626.1)

39

Rck
(AAL23513.1)

Serum
resistance.
Adherence,
Invasion

Outer
membrane
protein X
(YP 001438607.1)

170

37

100

2e-28

SodCI
(CADO 1927.1)

Stress
protein

Superoxide
dismutase
(YP 001438094.1)

172

77

99

3e-94

SpaR
(CAD05995.1)

Secretion
system

262

38

82

4e-10

SpaP
(AAO70353.1
)

Secretion
system

245

38

89

4e-38

InvA
(AAL21776.1)

Secretion
system

Flagellar
biosynthesis
protein FliR
(YP 001437346.1)
Flagellar
biosynthesis
protein FliP
(YP 001437348.1)
Flagellar
biosynthesis
protein FlhA
(YP 001437451.1)

692

34

97

6e-120

After pruning the list of the 29 homologues of Salmonella virulence factors found in the C
sakazakii BAA-894 genome, 22 proteins remain that are unique. This is because the other 7
proteins were doubled and deemed the same. For example, the C. sakazakii protein
ESA_02538, turned out to be the closest homologue of the Salmonella proteins LpfA and
LpfE, as well as being homologous to the Salmonella proteins FimA and FimF. The C.
sakazakii ESA_01974 protein was a homologue of Salmonella proteins LpfC, PefC and
FimD.

Of the 22 remaining C. sakazakii proteins it was found that 2 of them, hypothetical proteins
ESA_pESA3p05536 (MgtB homologue) and ESA_pESA3p05439 (Mig-14 homologue) are
encoded by genes on the pESA3 plasmid. The other 20 proteins are encoded by genes on the
chromosome.
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3.2.2 Predicting Putative Virulence Factors in C. sakazakii

Carranza et al. (2009) successfully mapped the proteome of C turicensis 3032 and
identified proteins that may be involved in C turicensis pathogenicity. C. sakazakii
homologues of the putative virulence factors that might be involved in C turicensis
pathogenicity are listed in the appendix (Table 3).

3.2.3 Analyzing the Subcellular Location

With the remaining 22 C. sakazakii putative virulence factor proteins, it was decided to use
the PSORT bioinformatic prediction program in order to determine the subcellular
localization of these proteins. The information from the analysis is listed in (Table 4).

Table 4. PSORTb prediction analysis of the putative virulence factor proteins.
Cronobacter sakazakii Protein
ESA 02538
ESA 02344
ESA 01974
ESA 02342
ESA 02539

PSORTb Prediction
Extracellular
Periplasmic
Outer membrane
Extracellular
Periplasmic

ESA_00987

Outer membrane

ESA 01976
ESA 01309
UDP-N-acetyl-D-mannosamine
dehydrogenase

Extracellular
Cytoplasmic
Cytoplasmic

ESA 01535
ESA 03359
ESA pESA3p05536
ESA pESA3p05439
Ferric uptake regulator
DNA-binding transcriptional
PhoP

Cytoplasmic
CytoplasmicMembrane
CytoplasmicMembrane
Unknown*
Cytoplasmic
regulator Cytoplasmic

Sensor protein PhoQ
RNA polymerase sigma factor RpoD
Outer membrane protein X

CytoplasmicMembrane
Cytoplasmic
Outer membrane
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Superoxide dismutase
Flagellar biosynthesis protein FUR
Flagellar biosynthesis protein FliP
Flagellar biosynthesis protein FlhA

Periplasmic
CytoplasmicMembrane
CytoplasmicMembrane
CytoplasmicMembrane

The subcellular location of the ESA_pESA3p05439 protein cannot be predicted. PSORTb
results for this protein were prediction scores of 2.0 for Cytoplasmic, CytoplasmicMembrane,
Periplasmic, Outer membrane and Extracellular regions. Through the use of PSORTb, it was
predicted that 12 of the 22 putative C sakazakii virulence factors were located within the
membrane or on the surface of the cell.

3.2.4 Determining Transmembrane Regions

After determining the subcellular location of the remaining putative virulence proteins, for
any that were found to be located in the membrane, the bioinformatic program TMHMM was
used to predict how many transmembrane regions these proteins possess. This is important
information as we are interested in proteins that will be within or on the membrane because
these types of proteins are the ones that would be involved in virulence, such as invasion and
adherence proteins. The proteins that were predicted to be located in the membrane along with
the corresponding number of predicted transmembrane regions (Table 5).

Table 5. Transmembrane regions predicted by TMHMM analysis.
Cronobacter sakazakii Protein

Number of Predicted
Transmembrane Regions

ESA_01974

0

ESA_00987

1

ESA_03359

6

Sensor protein PhoQ

2

Outer membrane protein X

1

Flagellar biosynthesis protein FliR

6

Flagellar biosynthesis protein FliP

5
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Flagellar biosynthesis protein FlhA

7

ESA_pESA3p05536

8

ESA_pESA3p05439*

0

An example of the results from the TMHMM analysis on ESA_pESA3p05536 is shown
(Figure 13). TMHMM analysis predicted that 10 of the 12 proteins that PSORTb predicted to
be in the membrane or on the cell surface have putative transmembrane regions.

TMHMM posterior probabilities for gi_1 56g36655_ref_YP_001440563.1_

0

100

200

300

400

transmembrane-------

500
inside ---------

BOO

700

800

900

outside ---------

Figure 13. TMHMM prediction results for ESA_pESA3p05536. Showing 8 predicted
transmembrane regions (Red).

3.2.5 Identifying Conserved Domains

The 10 proteins TMHMM analysis predicted to have transmembrane regions were searched
for conserved domains (Table 6).
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Table 6. Conserved domains present in the putative C. sakazakii virulence factors predicted to
have transmembrane regions by TMHMM.

Cronobacter

Size

sakazakii Protein

(Amino

Conserved Domains

E-value

acids)
ESA_01974

794

PRK15223 superfamily

Oe+00

Usher

Oe+00

ESA_00987

1027

Peptidase M14NE CP- C like superfamily

1.17e-03

ESA_03359

258

ABC2_membrane superfamily

6.52e-10

TagG

2.21e-30

Sensor protein PhoQ

501

PRK10815

Oe+00

HisKA

1.86e-06

PhoQ Sensor

2.31e-89

HATPase- C

3.38e-19

170

ompX PRK09408 superfamily

4.82e-89

Flagellar biosynthesis
protein FliR

286

fliRPRK05701 superfamily

2.53e-64

Flagellar biosynthesis
protein FliP
Flagellar biosynthesis
protein FlhA

245

flip PRK05699 superfamily

692

flhAPRK06012 superfamily
FHIPEP pfam00771 superfamily

1.49e-12
5
Oe+00
Oe+00

ESA_pESA3p05536

904

PRK15122 superfamily

Outer membrane
protein X

ESAj3ESA3p05439*

296

Oe+00

Cation ATPase superfamily- C

2.04e-20

Cation ATPase superfamily- N

2.85e-ll

E1-E2 ATPase superfamily

4.26e-52

HAD superfamily

5.02e-07

NAT SF superfamily

1.83e-03

PRK15312 superfamily

1.86e-57
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3.3 Identifying Putative Fimbrial Proteins in the C, sakazakii BAA-894
Genome
3.3.1 NCBI Keyword Search

Using the keyword search tool on the NCBI genome page, the C. sakazakii genome was
searched for potential virulence proteins using keywords related to adhesion. The results of
the searches are listed in (Table 7).

A total 19 results were obtained. No proteins were found when the keyword "fimbriae" was
used. When the keyword "fimbrial" was used 2 proteins were found. 6 proteins were found
when "adhesion" was used and 11 when "adhesin" was used.
Table 7. C. sakazakii proteins found using keywords related to adhesion.
Keyword

C.
sakazakii Accession #
Protein Hit

Fimbrial

Flagella
biosynthesis
protein FliZ
(ESA_01301)

Fimbrial

ATP-dependent
YP_001437783.1
RNA
helicase
HrpA
(ESA_01693)

1301

Adhesion

Hypothetical
protein
(ESA 02317)
Hypothetical
protein
(ESA_02516)

YP_001438402.1

563

YP_001438597.1

694

Adhesion

YPOO 1437399.1
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Size of
Protein
(Amino
acids)
182

Predicted Function

Activator of type
1
fimbrial gene expression

Involved in the post
transcriptional processing
of the daa operon mRNA,
which encodes proteins
involved
in
fimbrial
biogenesis
Large
exoproteins
involved
in
heme
utilization or adhesion
Large
exoproteins
involved
in
heme
utilization or adhesion

Adhesion

Adhesion

Adhesion

Outer membrane ABU77771
protein X
(ESA 02526)
YP_001439094.1
Hypothetical
protein
(ESA 03029)
Lipoprotein
ABU78368
involved
with
copper
homeostasis and
adhesion
(ESA_03145)

170

Involved in cell adhesion

663

Large
exoproteins
involved
in
heme
utilization or adhesion
Lipoprotein involved with
copper homeostasis and
adhesion

232

Hypothetical
protein
(ESA 03608)
Hypothetical
protein
(ESA 02797)
Hypothetical
protein
(ESA_02934)

YP_001439654.1

859

YP_001438863.1

829

YP_00143 8999.1

925

Type V secretory pathway,
adhesin AidA

Hypothetical
protein
(ESA 03758)
Hypothetical
protein
(ESA 00633)
Hypothetical
protein
(ESA 00983)
Hypothetical
protein
(ESA 00985)
Hypothetical
protein
(ESA_00986)

YP_001439790.1

1860

Autotransporter adhesin

YPOOl 436752.1

190

Autotransporter adhesin

YP_001437088.1

541

Autotransporter adhesin

YP_00143 7090.1

684

Autotransporter adhesin

YP_001437091.1

339

Autotransporter adhesin

Adhesin

Hypothetical
protein
(ESA_00987)

YP_001437092.1

1027

Autotransporter adhesin

Adhesin

Hypothetical
protein
(ESA_01673)

YP_001437763.1
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Type V secretory pathway,
adhesin AidA

Adhesion

Adhesin

Adhesin

Adhesin

Adhesin

Adhesin

Adhesin

Adhesin

46

Large
exoproteins
involved
in
heme
utilization or adhesion
Putative
autotransport
adhesin

Adhesin

Hypothetical
protein
(ESA 02084)

YP_001438170.1

2356

Adhesin

Hypothetical
protein
(ESA 02239)

YP_001438324.1

221

Putative autotransporter.
Type V secretory' pathway,
adhesin AidA
Collagen-binding surface
adhesion SpaP

3.3.2 Salmonella Fimbrial Proteins

Salmonella Typhimurium fimbrial proteins were selected and a BLAST search was
performed with each fimbrial protein, against the entire C sakazakii genome in order to
identify homologous putative fimbrial proteins (Table 8).

Table 8. C. sakazakii homologues of Salmonella fimbrial proteins.

Salmonella

C sakazakii

Percent

Protein

Homologue

Identity

(aecession #)

(aceession #)

%

FimA

ESA_02538

E-value

Details

36

5e-24

Hypothetical protein

27

8e-13

Hypothetical protein

40

le-45

Hypothetical protein

43

0

Hypothetical protein

30

5e-25

Hypothetical protein

32

le-13

Hypothetical protein

(YP_001438619.1)
FimI

ESA_01976
(YP_001438065.1)

FimC

ESA_02539
(YP_00143 8620.1)

FimD

ESA_01974
(YP_001438063.1)

FimH

ESA_02342
(YP_00143 8427.1)

FimF

ESA_02538
(YP_001438619.1)

47

FimZ

ESA_01309

28

2e-27

Response Regulator

32

0.40

Hypothetical protein

25

0.044

DNA-binding

(YP_001437407.1)
FimY

ESA_01291
(YP_001437389.1)

FimW

ESA_03390
(YP_001439444.1)

transcriptional
activator BglJ

3.3.3 E. coli Fimbrial Proteins

Fimbrial proteins were selected from E. coli str. K-12 and a BLAST search was performed
with each protein, against the entire C. sakazakii genome, to find homologous putative
fimbrial proteins (Table 9) .

Table 9. C sakazakii homologues of E. coli fimbrial proteins.

E. coli Protein
(Accession #)

Homologue in C
sakazakii

FimB

ESA 03747
(YP_001439780.1)

FimE

ESA 03747
(YP_001439780.1)

FimA

Percent
Identity
%
26

E-value

Details

4e-15

Site-specific
tyrosine
recombinase XerC

30

2e-18

Site-specific
tyrosine
recombinase XerC

ESA 02538
(YP_001438619.1)

38

le-23

Hypothetical Protein

FimI

ESA 02538
(YP_001438619.1)

29

5e-24

Hypothetical Protein

FimC

ESA 02344
(YP_001438429.1)

38

le-51

Hypothetical Protein

FimD

ESA 01974
(YP_001438063.1)

43

0.0

Hypothetical Protein

FimF

ESA 02538
(YP_001438619.1)

33

5e-22

Hypothetical Protein

48

FimG

ESA 01970
(YP_001438059.1)

40

5e-30

Hypothetical Protein

FimH

ESA 04070
(YP_001440087.1)

24

5e-07

Hypothetical Protein

3.4 Comparative Modelling of Putative C. sakazakii Fimbrial Proteins
Curtin (2011) identified 3 putative fimbrial production regions in the C. sakazakii
BAA-894 genome, along with putative FimH proteins. The regions are ESA_01970-76,
ESA_02534-42 and ESA_04067-73. Results from (Table 2) indicate a putative fimbrial
protein from a 4^*^ region, ESA_02342-45, The predicted fimbrial proteins analysed can be
seen in (Table 10). The proteins from these clusters potentially play a role in the virulence of
C. sakazakii.

Table 10. C. sakazakii gene clusters analysed.

Cluster

Loci

Predicted Fimbrial Protein in the

(Genes #)

Cluster

1.

ESAO1970-76

ESA_01973

2.

ESA_02342-45

ESA_02342

3.

ESA_02534-42

ESA_02539, ESA_02541

6.

ESA 04067-73

ESA 04070

A recent study by Joseph et al. (2012) further proves the existence of multiple fimbriae
gene clusters in the 7 members of the Cronohacter genus, with C. sakazakii BAA-894
possessing 8 of the 10 fimbriae gene clusters. The 10 Cronohacter fimbriae cluster
designations Joseph et al. (2012) identified can be seen in (Table 11).
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Table 11. Cronohacter fimbriae cluster designations. (Joseph et al, 2012)
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3.4.1 Identifvin2 Conserved Domains

The putative fimbrial proteins from the 4 putative C. sakazakii fimbriae gene clusters were
analysed for the presence of conserved domains (Figures 14-18). The subcellular location was
predicted using PSORTb and Signal?.
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Figure 14. ESA_01973 conserved domains.
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Figure 15. ESA_02342 conserved domains.
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Figure 16. ESA_02539 conserved domains.
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Figure 17. ESA_02541 conserved domains.
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Figure 18. ESA_04070 conserved domains.

Table 12. Summary of conserved domains and subcellular location.
C. sakazakii Conserved
Protein

ESA_01973

Predicted

Predicted

Domain(s)

Subcellular

Signal Peptide

Details

Location

Fimbrial

E-value

4.72e-08

Extracellular

superfamily
ESA_02342

Fimbrial

2.18e-51

Extracellular

Predicted signal
peptide

Pili assembly N

5.02e-56

superfamily

2.75e-12

Periplasmic
Predicted signal

Pili assembly C2
superfamily

signal

peptide

superfamily
ESA_02539

No

peptide
4.70e-67

FimC
ESA_02541

Fimbrial

7.19e-ll

Extracellular

superfamily
ESA_04070

Fimbrial

Predicted signal
peptide

3.41e-10

superfamily

Unknown*

Predicted signal
peptide

Results from the searches indicate ESA_01973 may be FimA protein and showed no signal
peptide. ESA_02539 may be a FimC chaperone protein. While the other 3 proteins
ESA_02342, ESA_02541 and ESA_04070 may be FimH proteins, as they all possess fimbrial
domains, and signal peptides were predicted except for in ESA_01973. Based on these results.
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homology searches and the size of the proteins it is likely that ESA_02539 encodes the FimC
chaperone/usher protein involved in assisting the folding of FimH.

Curtin (2011) suggested that ESA_02538 may be the structural FimA protein. It is also
highly likely that ESA_02541 is a FimH protein based on these results as well as results from
Curtin (2011) that predicted ESA_02541 to be FimH and ESA_02542 to be the FimF
counterpart based on the arrangement of the fim operon in Salmonella. The subcellular
location of ESA_04070 could not be identified by PSORT, but Signal? results suggest it is a
signal peptide with other results indicating it may encode another FimH protein,

3.4.2 Model Building

Based on results from the previous sections as well as the findings of Curtin (2011) and
Joseph et al. (2012), it was decided to model the putative fimbrial proteins from the 4 gene
clusters, predicting the tertiary structure of the putative FimH proteins, which should be at the
tip as they are in other type 1 pili and are involved in adherence. Doing this will give an
insight into the tertiary structure of the proteins and if they are FimH they should consist of
two domains, a lectin domain roughly (1-173) and a pilin domain (177-313), with a threonine
residue in the mannose binding lectin domain that has been reported to be critical for the
binding of mannose in S. enterica (Kisiela et al. (2005). As well as conserved cysteine
residues fanning stabilizing disulfide bonds in both domains. The proteins modelled can be
seen in (Table 12), and were modelled as described in the Materials and Methods (section
2.4.2).

ESA_01973:

Figure 19 shows the secondary structure of ESA_01973 as predicted by the Phyre2 server.
The 3D model was predicted using (clklfP, a FimH adhesin-FimC complex with D-mannose)
from E. coll as the best overall template (Figure 19.A and B appendix).
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Figure 19. Phyre2 secondary structure and disorder prediction for ESA_01973.

1 template was selected to model the protein based on heuristics to maximise confidence,
percentage identity and alignment coverage. Table 13 indicates where the sequence was
covered by each template, colour-coded by the confidence of the match to that template
overall. 61 residues were modelled by ab initio (note, ah initio modelling is highly unreliable).
81% of residues modelled at >90% confidence. The template used was Iklf chain P from E.
coli. A ribbon diagram of the model produced can be seen in (Figure 20. A) rainbow coloured
from N-C terminus.
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Figure 20.A Ribbon diagram of ESA_01973.

Table 13. Confidence scores and summary.
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Two models of this protein were produeed by the SWISS-MODEL server. Two templates
were used. For model 1 the template used was 2jmr ehain A (type 1 pilus subunit FimF,
monomer) from E. coli, with a sequence identity of 25.81% and an E-value of 1.50e-23. NMR
Resolution: 99.9. The modelled residue range for model 1 was 175 to 322. The model
produced was a single chain (Figure 20.B). QMEAN Z-Score: -5.36 (low scores, only
membrane proteins or models of poor quality are expected to reach such low scores).

Model 2, was produced using 3u4k chain A (receptor binding domain of plasmiadhesin
MRKDIP) from Klebsiella pneumoniae, with a sequence identity of 20.12% and an E-value
of 7.80e-24. NMR Resolution: 3.00. The modelled residue range was 31-188. The model
produced was a single chain. QMEAN Z-Score: -6.91 (Figure 20. C).

Figure 20.

B

Ribbon diagram of the protein modelled by I-TASSER (Figure 21.A) and

superimposed

with the best template 1 klfP, shows a very close resemblance to the template (purple ribbon)
(Figure 21.B). Templates used (21.C appendix.) and the EXPRESSO multiple sequence
alignment with the top templates can also be found in the appendix (Figure 21.D).
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B

Figure 21.

The multiple sequence alignment shows conserved cysteine residues between 215-277 in
the pilin domain. Two conserved threonine residues are present between positions 101-153 of
the lectin domain, suggesting mannose-binding capabilities.

ESA_02342:

Figure 22 shows the secondary structure of ESA_02342 as predicted by the Phyre2 server.
Although this protein is the C. sakazakii homologue of the Salmonella FimH protein, the best
overall template (IklfP) and one of 4 used to model the protein was the E. coll FimFI
adhesin-FimC chaperone complex with D-mannose (Figure 22. A and B appendix).

4 templates were selected to model ESA_02342 protein based on heuristics to maximize
confidence, percentage identity and alignment coverage. (Table 14) shows where the sequence
was covered by each template, colour-coded by the confidence of the match to that template
overall. 54 residues were modelled by ab initio (note: ab initio modelling is highly unreliable).
84% of residues modelled at >90% confidence.
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Figure 22. Phyre2 secondary structure and disorder prediction for ESA_02342,

The 4 templates used were Iklf chain P from E. coli, 2w07 chain B (minor pilin subunit
papf from E. coli), 3bfw chain A (FimG from E.coli) and 4dwh chain D (type-1 fimbrial
protein from E.coli). A ribbon diagram of the model produced is shown in (Figure 23).
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Figure 23.
Table 14. Confidence scores and summary,
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Two models of this protein were produced by SWISS-MODEL. Two templates were used.
For model 1 the template used was 2w07 chain B (P pilus adaptor subunit PapF, heterodimer)
from E. coli, with a sequence identity of 18.37% and an E-value of 1.60e-26. NMR resolution:
2.20. The modelled residue range was 197 to 342. The model produced was a single chain
(Figure 24.A). QMEAN Z-Score: 0.

Model 2 was produced using the template 3u4k chain A (MrkDlP receptor binding domain,
monomer) from Klebsiella pneumoniae, with a sequence identity of 14.29% and an E-value of
1.60e-9. NMP. Resolution: 3.00. The modelled residue range was 26-205. The model
produced was a single chain (Figure 24.B). QMEAN Z-Score: 0.

Figure 24.

B

Ribbon diagram of the protein modelled by I-TASSER (Figure 25.A), superimposed with
the top template IklfP, shows a very close resemblance to the template (purple ribbon) (Figure
25.B). The top templates used (Figure 25.C appendix) and the EXPRESSO multiple sequence
alignment with the top templates can also be found in the appendix (Figure 21.D). The
alignment shows conserved cysteines in the lectin domain between positions 1-45, and
between 162-209 most likely the pilin domain.
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Figure 25.

ESA_02539:

Figure 26 shows the secondary structure of ESA_02539 as predicted by the Phyre2 server.
The best overall template (2co7) and one of 5 used to model the protein was the
Salmonella enterica SafA pilin in complex with the SafB2 chaperone (type ii) (Figure 26.A
and B appendix), the EXPRESSO multiple sequence alignment with the top templates can
also be found in the appendix (Figure 26.C). Conserved threonines could not be seen. Results
suggest that this protein most likely functions as FimC.
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Figure 26. Phyre2 secondary structure and disorder prediction.

5 templates were selected to model the ESA_02539 protein based on heuristics to maximize
confidence, percentage identity and alignment coverage. (Table 15) shows where the sequence
was covered by each template, colour-coded by the confidence of the match to that template
overall. 92% of residues modelled at >90% confidence.
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17 residues were modelled by ah initio. A ribbon diagram of the model produced is shown
in (Figure 27. A).

Figure 27.A

Table 15. Confidence scores and summary.
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One model of the protein was produced by the SWISS-MODEL server. One template was
used to model the protein. Template 4b0m (complex of CaflAN usher domain, CaflM
chaperone and Cafl subunit, hetero trimer) from Yersinia pestis. With a sequence identity of
39.71% and an E-value of O.OOe-1. NMR resolution: 1.80. The modelled residue range was 14
to 222. The model built was a single chain (Figure 27.B). QMEAN Z-Score: -1.72.

Figure 27.

B

ESA_02541:

Figure 28 shows the secondary structure of ESA_02541 as predicted by the Phyre2 server. A
ribbon diagram of the model is shown in (Figure 29). The best overall template (IklfP) was
the only one used to model the protein (Figure 29.A and B appendix).
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Figure 28. Phyre2 secondary structure and disorder prediction.
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Figure 29.

1 template was selected to model ESA_02541 based on heuristics to maximise confidence,
percentage identity and alignment coverage, i.d was 23%. (Table 16) shows where the
sequence was covered by each template, colour-coded by the confidence of the match to that
template overall. 80% of residues modelled at >90% confidence. 67 residues were modelled
by ab initio. The EXPRESSO multiple sequence alignment with the top templates can be
found in the appendix (Figure 29.C). The alignment shows 3 conserved threonines in the
lectin domain, one between positons 64-110 and 2 between positions 111-169, along with
conserved cysteines in the pilin domain, supporting the idea that this may be a FimH protein,
although transmembrane helices were predicted in this sequence, to adopt the topology as
seen in Figure 30.
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Table 16. Confidence scores and summary.
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Figure 30. Transmembrane helices predicted in the ESA_02342 sequence.

Two models of the protein were produced by the SWISS-MODEL ser\^er. Two templates
were used. For model 1 the template used was 2jty chain A (Fusion protein of Type-1 fimbrial
protein and type-1 fimbrial protein, monomer) from E. coli. The sequence identity was
27.92% with an E-value of 6.50e-22. NMR resolution: 99.9. The residue modelled range was
189 to 335. The model generated was a single chain (Figure 30.A). QMEAN Z-Score: -4.09.
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Model 2 was produced using the template 3u4k chain A monomer from E. coli (this
template was mentioned previously). The sequence identity was 21.71% with an E-value of
1.40e-17. NMR resolution: 3.00. The modelled residue range was 36 to 205. The model built
was single chain (Figure 30.B). QMEAN Z-Score: -5.94.

B

Figure 30.

ESA_04070:

Figure 31 shows the secondary structure of ESA_04070 as predicted by the Phyre2 server. 1
template was selected to model your protein based on heuristics to maximise confidence,
percentage identity and alignment coverage, i.d. was 17%.
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Figure 31. Phyre2 secondary structure and disorder prediction.
Table 17 shows where the sequence was covered by each of the templates, colour-coded by
the confidence of the match to the template overall. 81% of residues modelled at >90% confidence.
60 residues were modelled by ah initio. A ribbon diagram of the model is shown in Figure 32.
The best overall template (IklfP) was the only one used to model the protein (Figure 32.B and
C appendix).
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The EXPRESSO multiple sequence alignment with the top templates can also be found in
the appendix (Figure 32.D). As ESA_04070 is the C sakazakii homologue of the E. coli
FimH (IklfP), it was not a surprise that IklfP was the best template (IklfP is the FimH
Adhesin-FimC chaperone complex with D-mannose). The alignment shows that ESA_04070
has 1 conserved threonine in the lectin domain between positions 64-96 and 2 between
100-152, this suggests that this protein may have mannose-binding abilities.

Figure 32.

Table 17. Confidence scores and summary,
flklfP

100%
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100%
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Three models of the protein were produced by the SWISS-MODEL server. Three templates
were used. For model 1 the template used was 3u4k chain A monomer from E. coli (as
mentioned previously). The sequence identity was 21.26% with an E-value of 1.50e-25. NMR
resolution: 3.00. The modelled residue range was 27 to 199. The model produced was a single
chain (Figure 33.A). QMEAN Z-Score: -6.29.

Model 2, was produced using the template 2jty chain A monomer from uropathogenic E.
coli (as mentioned previously). Sequence identity was 19.33% with an E-value of 2.80e-21.
The modelled residue range was 185 to 323. Model built was a single chain (Figure 33.B).
QMEAN Z-Score: -4.76.

Figure 33.
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Model 3, was generated using the template 3jwn chain H hetero pentamer from E. coli kl2
(mentioned previously). Sequence identity was 16.95% with an E-value of 1.50e-32. The
modelled residue range was 100 to 323. The model built was a single chain (Figure 33.C).
QMEANZ-Score:-5.61.

Figure 33.

Ribbon diagram of the protein modelled by I-TASSER (Figure 34.A), superimposed with
the top template IklfP, shows a very close resemblance to the template (purple ribbon) (Figure
34.B). The top templates used (Figure 34.C appendix).
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Figure 34.A

B

3.4.3 Model Evaluation

Once the tertiary (3D) structure of the putative fimbrial proteins had been predicted by the
Phyre2 server, the best ranked model was sent to the 3DLigandSite server to identify
predicted binding sites in the protein. A direct link was provided to this site from the Phyre2
results page generated for each C. sakazakii protein submitted to Phyre2.

ESA 01973:

Two ligand clusters were identified. Predicted binding site residues in the model are shown
in (blue), heterogens (green), other residues (grey) (Figure 35.A). Cluster 1 predicted to have
4 ligands is shown in the predicted binding pocket (red circle) (zoomed in Figure 35.B). The
heterogens predicted in the binding site were MAN and NAG
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Figure 35.

Cluster 2 was predicted to have 1 ligand circled in (red) (Figure 35.C), a NAG heterogen
was also predicted. 2 threonine residues at position 81 and 83, as well as a cysteine residue at
position 75 are predicted to fonn the binding pocket.

More information on the predicted clusters and residues can be found in the appendix (Table
18.1 and 2).
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ESA_02342:

One ligand cluster was identified. Predicted binding site residues in the model are shown in
(blue), heterogens (green), other residues (grey) (Figure 36.A). The cluster was predicted to
have 4 ligands and is shown in the predicted binding pocket (red circle) (zoomed in Figure
36.B).

Figure 36.

MAN and NAG were found in the predicted binding site. Along with a threonine at position
183. More information on the predicted cluster and residues can be found in the appendix
(Table 19).
ESA_02359:
A total of 36 predicted ligand clusters were identified in this protein. Predicted binding site
residues in the model are shown in (blue), heterogens (green), other residues (grey) (Figure
37.A). The predicted binding pocket (red circle) (zoomed in Figure 37.B).
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Figure 37.

The predicted binding site contains 3 amino acids, a glycine at position 91, a leucine at
position 92 and a asparagine at 93. More infonnation can be found in the appendix (Table 20).
These results further support the idea that this protein is a FimC protein.

ESA_02541:

One ligand cluster was identified. Predicted binding site residues in the model are shown in
(blue), heterogens (green), other residues (grey) (Figure 38.A). The cluster was predicted to
have 4 ligands and is shown in the predicted binding pocket (red circle) (zoomed in Figure
38.B).
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Figure 38.

The predicted binding site contains 3 amino acids, a lysine at position 35, and a threonine at
positions 179 and 182. NAG and MAN were also predicted in the binding site. More
information can be found in the appendix (Table 21). These results indicate mannose-binding
potential, although this contradicts the Phyre results for this protein which predicted this
protein to be a transmembrane protein.

ESA_04070:

One ligand cluster was identified. Predicted binding site residues in the model are shown in
(blue), heterogens (green), other residues (grey) (Figure 39.A). The cluster was predicted to
have 4 ligands and is shown in the predicted binding pocket (red circle) (zoomed in Figure
39.B).
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Figure 39.

The predicted binding site contains 3 amino acids, a threonine at position 25, an alanine at
position 26 and a second threonine at position 78. NAG and MAN were also predicted be
present in the binding site. More information can be found in the appendix (Table 22). These
results further suggest that this protein may be a FimH.

3.5 Further Analysis of the Putative C. sakazakii FimH Proteins
3.5.1 Predicting Protein-Protein Interactions Usin2 STRING

It was decided to explore the putative FimA, FimC and FimH proteins further by submitting
each sequence to the STRfNG database for analyses, to assess whether or not they interact
with proteins in the same cluster, or if a protein from one cluster interacts with a protein from
a different cluster. Interaction network diagrams for each of the proteins were created. See
appendix (Figures 40-45). The results from the STRING analysis predicted possible
protein-protein interactions between ESA_0I973 and proteins in the ESA_02542 cluster,
these results agree with previous findings by Curtin (2011) who also predicted possible
protein-protein interactions between proteins in the ESA_02538 and ESA_0I975 regions.
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indicating that the C. sakazakii Fim proteins encoded by different gene clusters may interact
with one another.

It was shown that ESA_02342 is predicted to interact with

ESApESA3p05458, whereas none of the other putative fimbrial proteins were shown to
interact with the plasmid.
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4. Discussion/Future Prospects
Some of the clinical symptoms of Cronobacter infection include necrotizing enterocolitis,
bacteremia, and meningitis, with case fatality rates of 50-80% being reported (Healy et al.
2010). Some neonatal Cronobacter infections have been associated with the use of PIF with
some strains able to survive in a desiccated state for more than two years (Caubilla-Barron J.
et al. 2007). At present, little is known about the virulence mechanisms used by Cronobacter
sakazakii to interact with a human host and cause disease. The complete genome of C.
sakazakii BAA-894 was sequenced by Kucerova et al. (2010). The aim of this project was to
analyse the genome and predict proteins involved in the interaction between C. sakazakii and
a human host, especially those involved in the virulence process.

C. sakazakii was compared to other members of the Enterobacteriaceae family, in order to
determine the evolutionary relatedness between the different Gram negative species. By doing
this it could give an insight into the virulence mechanisms used by C. sakazakii, as there is a
high possibility that the species most closely related to C sakazakii uses the same virulence
mechanisms. Having detennined the relatedness of the Enterobacteriaceae members via
creation of a phylogenetic tree, it could be seen that Escherichia coli and Salmonella bongori
were the most closely related species to C. sakazakii. The species chosen to perform a
pairwise sequence comparison with C. sakazakii was S. bongori, using the genome
comparison tool ACT. The alignment produced with ACT showed a strong similarity
(homology) between S. bongori and C. sakazakii. Salmonella virulence factors have been well
characterized for many years, and having shown the strong similarity between S. bongori and
C. sakazakii, it was decided to research various Salmonella virulence factors and search for
homologues of these within the C. sakazakii genome.

80 Salmonella virulence factors were selected from the Virulence Factor Database and C.
sakazakii homologues of these proteins were searched for by carrying out BLAST analysis.
22 homologues were identified and are predicted to carry out a variety of functions that may
be important for survival of the organism within the host such as immune evasion or
resistance to antimicrobials, as well as functions involved in adherence to host cells. As
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virulence factors such as proteins involved in adherence would not be located within the
cytoplasm, it was decided to prune the list of potential cytoplasmic proteins by predicting the
subcellular location of the putative C. sakazakii virulence factors. Results from PSORTb
predicted that 12 of the 22 proteins were located within the membrane or on the cell surface.

After determining the subcellular location of the remaining putative virulence proteins, the
proteins were analysed for transmembrane regions, this was important as transmembrane
proteins are usually involved in the interaction between the host and bacteria, are located
within or on the membrane and are ones that would be involved in virulence, such as
adherence proteins. Multiple proteins that may potentially play a role in adhesion to human
cells were identified such as fimbrial proteins. As an in depth analysis of all predicted
virulence factors would have taken longer than the allowed timeframe for this project it was
decided to focus on proteins involved in adhesion. Fimbrial adhesin proteins were specifically
chosen for further analyses for several reasons. Adhesion is a key factor in the early stages of
infection of gastrointestinal pathogens which usually must adhere to intestinal cells and then
invade (Kline et al. 2008). The exact proteins involved in adherence of C. sakazakii to human
host cells are still unknown. It has been shown however, that C. sakazakii adhesin genes are
strain and species variable (Healy et al. 2009). It is possible that variances in the number of
adhesin genes may be responsible for the ditferences in virulence of Cronohacter strains and
species. Adhesin genes/proteins can also be involved in the formation of biofilms, which may
be a major factor enabling C. sakazakii to survive in PIF and the factories in which it is
produced.

Type 1 fimbriae (encoded by fim genes) play a role in adhesion in Salmonella and E. coli
and the proteins involved are well characterized (Mange et al. 2006). For the present study it
was decided to focus on FimH as this protein is located at the tip of type 1 pili so interacts
directly with the host. Two approaches were used in the identification of C. sakazakii fimbrial
proteins. The first was performed by searching the genome for genes containing fimbrial
related terms in their annotations, as well as identifying homologues of Salmonella and E. coli
Fim proteins.

Curtin (2011) identified 3 putative fimbrial production regions in the C. sakazakii BAA-894
genome, along with putative FimH proteins. The regions are ESA_01970-76, ESA_02534-42
and ESA_04067-73. Results from (Table 2) indicate a putative fimbrial protein from a 4^
region, ESA_02342-45. Joseph et al. (2012) reported the presence of 10 fimbrial clusters in
Cronohacter species; C. sakazakii possess 8 of these. Four of these clusters were selected for
analysis; one cluster contains the closest homologue to E. coli FimH, ESA_04070, while
another cluster contains the Salmonella FimH homologue ESA_02342. The reasons the other
two regions were chosen is the ESA_02538 region is strain variable (i.e. present in some C.
sakazakii strains but not others) and the ESA_01973 cluster is found in C. sakazakii but not
other Cronohacter species (Joseph et al. 2012).

The putative FimH proteins (Table 11) encoded by genes from the 4 gene clusters, were
analysed for the presence of conserved fimbrial domains. If they are fimbrial proteins then
there should be conserved fimbrial domains within them. The results showed that the 5
putative fimbrial proteins all possess conserved fimbrial domains, further showing evidence
that C. sakazakii may produce fimbriae. Using the knowledge obtained from the conserved
domain searches (and their E-values), as well as amino acid length of the sequences, it was
concluded that the proteins selected for investigation were indeed likely to function as FimH
proteins in C. sakazakii.

Based on all the findings up to this point, it was decided to try to predict the tertiary
structure of the putative FimH proteins through comparative or (homology) modelling. The
FimH proteins are assisted by molecular chaperone/usher proteins, such as FimC which help
the FimH protein fold correctly. Salmonella and E. coli FimH proteins consist of two domains,
the N-terminal mannose-binding lectin domain and the C-terminal pilin domain, that are
linked by a short peptide. If models of the putative C sakazakii fimbrial proteins showed a
resemblance to the Salmonella and E. coli lectin and pilin domains, it is likely that they are
FimH proteins. Cysteine residues in these domains in Salmonella and E. coli FimH proteins
are conserved and form stabilizing disulfide bonds in the lectin (Cys3-Cys47) and pilin
(Cys 178-220) domains. More importantly, a threonine residue at position 56 has been
previously reported to be critical for mannose binding of S. enterica FimH (Kisiela et al.
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2005).
Building a model of the predicted FimH proteins allowed for the visualisation of the 3D
structure and also for the prediction of potential binding sites and the possible identification of
a threonine in the lectin domain needed to bind mannose, which would indicate a potential
mannose-binding FimH protein. Models were produced for each of the proteins examined
from 4 different fimbriae clusters the ESA_01970-76, ESA_02342-45, ESA_02534-42 and
ESA_04067-73 cluster. For the putative fimbrial protein from the first cluster, ESA_01973,
the results seem to contradict each other, in that a FimA domain was shown to be present,
meanwhile the E. coli (IKLFP) FimH adhesin-FimC complex was the best template. The
multiple sequence alignment showed conserved cysteine residues between 215-277 in the
pilin domain. Two conserved threonine residues are present between positions 101-153 of the
lectin domain, suggesting ESA_01973 may have mannose-binding capabilities. Analysis of
ESA_02539 suggests that this protein is most likely a FimC usher/chaperone protein. The
alignment for ESA_02541 showed 3 conserved threonines in the lectin domain, along with
conserved cysteines in the pilin domain, supporting the idea that this may be a FimH protein,
although transmembrane helices were predicted in this sequence. The alignment for
ESA_02342 showed conserved cysteines in the lectin domain between positions 1-45, and
between 162-209 most likely the pilin domain. The ESA_04070 alignment showed conserved
threonines in the lectin domain between positions, so this protein may also have
mannose-binding abilities. ESA_02342, ESA_02541, and ESA_04070 are most likely FimH
proteins although further structural studies of these proteins will have to be carried out in the
future do try and predict more accurate models with a more in depth analysis. All proteins
showed the heterogens NAG and MAN in the predicted binding site except for ESA_02539
which was shown to have a CA heterogen. This suggests that ESA_02539 may bind to a
different oligosaccharide receptor than the other proteins. This may explain why C sakazakii
has multiple FimH proteins and why it can adhere to various human cells as shown by Hunter
et al. (2008), Mange et al. (2006) and Townsend et al. (2007).
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The production of fimbriae by C sakazakii has been investigated by (Mange et al. 2006) but
their electron microscopy experiments did not identify fimbriae. Type 1 fimbriae in
Salmonella and E.coli are controlled in response to environmental conditions especially since
fimbriae can trigger host immune responses (Kline et al. 2009). For example fim genes are
expressed in Salmonella cultures growing in LB broth, but are not expressed by bacteria
growing on agar plates (McFarland et al. 2008). It is therefore reasonable to assume that
possibly the conditions used by Mange et al. (2006) were not ideal for the strains of C.
sakazakii that were tested. According to the classification scheme proposed by Nuccio and
Baumler (2007) for fimbrial operons, the C. sakazakii ESA_02538 to ESA_02542 operon
likely belongs to the clade of classical usher/chaperone family. The leucine-responsive
regulatory protein has been shown to be involved in controlling fim expression in both
Salmonella and E. coli (McFarland et al. 2008). Analysis by Curtin (2011) revealed the
presence of consensus Lrp binding sites, suggesting that Lip may also play a role in regulating
fim genes in C. sakazakii.

The multitude of biological effects mediated by type 1 fimbriae could depend on the fact
that the FimH adhesin binds to mannose residues on glycoproteins. Hence a multitude of host
cell glycoproteins are potential receptors for the FimH lectin (Kline et al. 2009). The variety
of different /zw genes present in C. sakazakii genome may allow the organism to adhere to
different cell receptors, therefore C. sakazakii would be capable of infecting various cell types
such as brain cells or intestinal epithelial cells.

In summary, putative virulence factors involved in the interaction of C. sakazakii with a
human host were identified and in particular, the fimbrial adhesin FimH proteins from 4
different gene clusters were chosen for further analysis. Analysis also predicted possible
protein-protein interactions between ESA_01973 and proteins in the ESA_02542 cluster,
these results agree with previous findings by Curtin (2011) who also predicted possible
protein-protein interactions between proteins in the ESA_02538 and ESA_01975 regions,
indicating that the C. sakazakii Fim proteins encoded by different gene clusters may interact
with one another.
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The findings of this thesis could be further investigated through wet-lab experiments. The
presence of C. sakazakii Fim proteins and their functions should be explored further, under a
variety of conditions, unlike the Mange et al (2006) study. Since host cells can contain several
carbohydrate residues that serve as receptors for bacterial adhesin proteins, it would be
interesting to examine the adhesion of C sakazakii onto different cell types in the presence of
different carbohydrates, such as glucose, galactose or fructose. Binding of FimH to host cells
involves mannose-binding of oligosaccharides. Quintero et al. (2011) demonstrated that
adherence of C sakazakii to intestinal cells could be inhibited by prebiotic oligosaccharides,
this warrants further research into the inhibition of C. sakazakii using prebiotics.

Another study could involve mutating the putative fimbrial proteins identified in this
present study, and comparing them to the wild type strain to analyse their adhesion to human
cell lines. The creation of site specific mutations could also be performed, by mutating the
regions involved in binding to the host and observing the effects on binding. The production
of fimbriae by C. sakazakii most definitely calls for further research and the results provided
by this thesis should guide any possible future studies.
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6. Appendices
3.2.1 Identification of Homologues of Salmonella Virulence Factors within the C.
sakazakii Genome

Table 2.A Details of the Salmonella virulence factors and their best BLAST hit against the C.
sakazakii BAA-894 genome.

Gene
from
Salmonella
(Accession #)
LpfA
(AAL22500.1)

Function in Salmonella

LptB

Adhesion.
Long polar fimbrial chaperone precursor. Required for the biogenesis of
long polar fimbria.

(AAL22499.1)

Adhesion.
Mediates attachment to the Peyer’s patches.

LpfC
(AAL22498.1)

Adhesion.
Long polar fimbrial outer membrane usher protein. Involved in the export
and assembly of LpfA fimbrial subunits across the outer membrane.

LptD
(AAL22497.1)

Adhesion.
Long polar fimbrial protein.

LpfE
(AAL22496.1)

Adhesion.
Long polar fimbrial protein.

PefC
(AAL23521.1)

Adhesion.
Mediates binding of the bacteria to the microvilli of enterocytes.

PefD
(AAL23520.1)

Adhesion.
Fimbrial biosynthesis; sequence related to periplasmic chaperones.

SinH
(AAL21411.1)
FimA
(CAD05025.1)

Adhesion.
Involved in intestinal colonization and persistence.
Adhesion.
Type-1 fimbrial protein subunit A.

FimC
(AAL 19499.1)

Adhesion.
Periplasmic chaperone. Required for the biogenesis of type 1 fimbriae.
Binds and interacts with FimH.
Adhesion.
Involved in the export and assembly of FimA fimbrial subunits across the

FimD
(AA069911.1)
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outer membrane.
FimF
(AAL19502.1)
FimH
(AAL19501.1)
FimI
(AAL 19498.1)
FimZ
(AAL 19503.1)
TviB
(AA071805.1)

IviC
(AA071804.1)

VexB
(AA071800.1)

MgtB
(AAL22621.1)
Fur
(AAL19637.1)

Adhesion.
Fimbrial-like protein.
Adhesion.
The adhesin FimH mediates T3 SSI-independent uptake in murine
Adhesion.
Type-1 fimbrial protein.
Adhesion.
Putative fimbriae protein synthesis regulator.
Immune Evasion.
Prevents antibody-mediated opsonization, increase resistance
peroxide and resistance to complement activation by the alternate
and complement-mediated lysis.
Immune Evasion.
Prevents antibody-mediated opsonization, increase resistance
peroxide and resistance to complement activation by the alternate
and complement-mediated lysis.
Immune Evasion.
Prevents antibody-mediated opsonization, increase resistance
peroxide and resistance to complement activation by the alternate
and complement-mediated lysis.
Magnesium uptake.
Magnesium transporter.

DCs.

to host
pathway

to host
pathway

to host
pathway

Regulation.
Negatively regulates a number of operons that encode enzymes involved in
iron transport; activated by manganese; forms a homodimer.

PhoP
(AAL20160.1)

Regulation.
Response regulator in two-component regulatory system with PhoQ;
involved in magnesium starvation and stress.

PhoQ
(AAL20159.1)

Regulation.
Virulence sensor protein PhoQ; in two-component regulatory system with
PhoP; ligand is Mg+.

RpoS
(AAL21804.1)

Regulation.
Sigma factors are initiation factors that promote the attachment of RNA
polymerase to specific initiation sites and are then released; this sigma
factor controls the regulation of genes required for protection against
external stresses.
Resistance to antimicrobial peptides.
Mig-14 is an inner membrane-associated protein, necessary for bacterial
proliferation in the liver and spleen. Mig-14 may prevent the penetration of
the inner membrane by cathelin-related anti-microbial peptide (CRAMP),
an anti-microbial peptide expressed at high levels in activated mouse
macrophages. This resistance is important to the survival of Salmonella in
systemic sites during both acute and persistent infection.

Mig-14
(AAL21667.1)
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Rck
(AAL23513.1)

Serum resistance, Adherence, Invasion.
Confers serum resistance by binding human complement factor H. Rck
mediates cell invasion through a Zipper-like mechanism.

SodCI
(CADO 1927.1)

Stress protein.
Copper and zinc binding; converts superoxide radicals to hydrogen
peroxide and water. Contribute to survival during systemic phase of
infection.
Secretion system.
Virulence associated secretory protein. Contains possible membrane
spanning hydrophobic domains.
Secretion system.
Part of a type III secretory system probably involved in invasion into
eukaryotic cells.
Secretion system.
Affects invasion but not attachment to cultured epithelial cells.
Required for protein secretion.

SpaR
(CAD05995.1)
SpaP
(AAO70353.1)
InvA
(AAL21776.1)

3.2.2 Predicting Putative Virulence Factors in C. sakazakii
The C. sakazakii genome was searehed for homologues of the potential C. turicensis
virulenee proteins that Carranza et al. identified. Each of the potential virulence proteins
underwent BLAST? against the entire C. sakazakii genome. If significant hits are produced
then it can be said that the C. sakazakii protein most likely has the same function. These
proteins may be involved in numerous biological processes such as secretion and transport
systems, iron or copper acquisition and the protection against reactive oxygen radicals.

Table 3. Predicted putative virulence factors in C. sakazakii.

C
sakazakii
BAA-894
Protein & Gene #
Outer Membrane
Protein
A
(ESA 02391)
Outer membrane
channel
protein
(ESA 00373)

Predicted Protein Function

Porin, involved in diffusion of nonspecific
small solutes across the outer membrane
Trimeric outer membrane protein involved
in efflux of hydrophobic/amphipathic
molecules
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Protein Size
(Amino
acids)
358

GenBank
Accession #

497

ABU75671.1

ABU77637.1

Outer membrane Outer membrane receptor of ferric
receptor
FepA enterobactin and colicins B and D.
(ESA_01552)
Interacts with the TonB-ExbBD complex
which catalyzes the translocation of the
siderophore to the periplasmic space

729

ABU76806.1

Sec-independent
translocase
(ESA_03723)

Mediated the export of protein precursors
bearing twin-arginine signal peptides

186

ABU78920.1

Preprotein
Involved in protein export functions
translocase subunit
SecA
(ESA 03240)
Preprotein
Molecular chaperone required for the
translocase subunit normal export of envelope proteins out of
SecB
the cytoplasm
(ESA 04118)
Preprotein
Involved in secretion
translocase subunit
SecG
(ESA 03566)
Delta-aminolevulin Catalyzes
the
formation
of
ic acid dehydratase porphobilinogen from 5-aminolevulinate
(ESA 02936)
Porphobilinogen
Transformation of porphobilinogen to
hydroxymethylbilane
in
porphyrin
deaminase
(ESA_03753)
biosynthesis

901

ABU78462.1

174

ABU79299.1

no

ABU78777.1

304

ABU78165.1

313

ABU78950.1

Coproporphyrinog Catalyzes
the
oxegen-independent
en
Ill
oxidase fomiation of protoporphyrinogen-IX from
coproporphyrinogen-III
(ESA_04045)

457

ABU79226.1

Putative
Uncharacterized
enzyme
of
heme
uroporphyrinogen
biosynthesis
III
C-methyltransferas
e (ESA 03755)
Putative
Uncharacterized
enzyme
of
heme
protoheme
IX biosynthesis
biogenesis protein
(ESA 03756)
Frataxin-like
Based on phylogenomic distribution this
protein
protein may have a role in iron-sulfur
cluster protein assembly
(ESA_03751)

398

ABU78952.1

398

ABU78953.1

106

ABU78948.1

97

Bacterioferritin
(ESA_04406)

158

ABU79585.1

165

ABU76578.1

167

ABU77893.1

751

ABU77395.1

Manganese binding. Destroys free radical

211

ABU79029.1

Catalyzes
the
hydrolysis
of
1,4-beta-D-glucosidic linkages in cellulose,
lichenin and cereal beta-D-glucans
Catalyzes
the
formation
of
phosphoenolpyruvate
from
2-phospho-D-glycerate in glycolysis

371

ABU79386.1

432

ABU75814.1

Rotamase

275

ABU79573.1

Type V secretory pathway, adhesin AidA

2356

YP 0014382
55.1

Glyceraldehyde-3-phosphate
dehydrogenase/erythrose-4-phosphate
dehydrogenase
Manganese catalase

331

YP 0014382
55.1

301

YP 0014379
62.1

Kinase activity

477

YP 0014399
42.1

activity,

871

YP 0014399
43.1

Protein of avirulence locus involved in
temperature-dependent protein secretion

277

YP 0014399
47.1

Iron storage protein

Ferritin
Cytoplasmic iron storage protein
(ESA 01318)
Ferric
uptake Negatively regulates a number of operons
regulator
that encode enzymes involved in iron
(ESA 02653)
transport
Hydroperoxidase
Catalase HPII. Monofunctional catalase
11 (ESA_02146)
that decomposes hydrogen peroxide into
water and oxygen. Also protects cells from
the toxic effects of hydrogen peroxide
Superoxidase
dismutase
(ESA 03843)
Endo-1,4-D-glucan
ase (ESA_04206)
Phosphopyruvate
hydratase
(ESA_00523)
FKBP-type
peptidyl-prolyl
cis-trans isomerase
(ESA 04394)
Hypothetical
protein
(ESA 02084)
Hypothetical
protein
(ESA 02170)
Hypothetical
protein
(ESA 01872)
Hypothetical
protein
(ESA_03920)
Hypothetical
protein
(ESA 03921)
Hypothetical
protein
(ESA 03925)

ATPases
with
chaperone
ATP-binding subunit
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Hypothetical
protein
(ESA 03928)
Hypothetical
protein
(ESA 03934)
Hypothetical
protein
(ESA 03941)
Hypothetical
protein
(ESA 03942)
Hypothetical
protein
(ESA 03945)
Hypothetical
protein
(ESA 02807)
Hypothetical
protein
(ESA 00752)
H>p)othetical
protein
(ESA 03317)

Uncharacterized
conserved
contains FH A domain

protein,

643

YP 0014399
50.1

Hemolysin-coregulated
(uncharacterized)

protein

160

YP 0014399
56.1

Uncharacterized
bacteria

protein

conserved

in

499

YP 0014399
62.1

Uncharacterized
bacteria

protein

consei'ved

in

178

YP 0014399
64.1

Uncharacterized
bacteria

protein

conserved

in

1206

YP 0014399
67.1

Membrane-fusion protein

401

YP 0014388
73.1

Extracellular metalloprotease

341

YP 0014368
65.1

Exochitinase

695

YP 0014393
74.1
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3.4.2 Model Building

ESA 01973:

Figure 19. A PDB image of IkltP, deemed the best overall template.

Aligned region

Figure 19.B Domain results as predicted by Phyre2.
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Figure 21.C Templates used by I-TASSER.
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Figure 21.D EXPRESSO multiple sequence alignment of ESA_01973 with templates with
3JWN, IKLFP and Salmonella FimH.
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ESA 02342:

Figure 22.A PDB image of IklfP, deemed the best overall template.
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Figure 22.B Domain results as predicted by Phyre2.
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Figure 25.C Templates used by I-TASSER.
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Figure 25.D. EXPRESSO multiple sequence alignment of ESA 02342 with templates IKLFP
and 3BFWA.
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ESA 02539:

Figure 26.A PDB image of 2co7 chain B, deemed the best overall template.

Aligned region
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Figure 26.B Domain results as predicted by Phyre2.
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Figure 26.C EXPRESSO multiple sequence alignment of ESA_02539 with templates IKLFP
and 1L4IA.
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ESA 02541:

Figure 29.A PDB image of IklfP, best template.

Aligned region

clklfP^

Figure 29.B Domain results as predicted by Phyre2.
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Figure 29.C EXPRESSO multiple sequence alignment of ESA_02541
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yii.

Hi

315

ESA 04070:

Figure 32.B PDB image of IKLFP, best template.

Aligned region
clklfP_

c3u4kA.

10

Figure 32.C Domain results as predicted by Phyre2.
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Top 10 Identified stuctural analogs in PDB
Rank P06 Iclenl iden2 Cov. Norm.
HU
Z-score

1.60
4 15

Rank PDB TM-score RMSD^ IDEN^ Cov.
Hit

o

1

1klP

0.788

1 59

0.153 0.827

2

3f83A

0.583

4.53

0.072 0.784

Figure 34.C Top templates used by I-TASSER.
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Figure 32.D EXPRESSO multiple sequence alignment of ESA 04070 with templates IKLFP
and 3JWN..
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3.4.2 Model Evaluation

ESA 01973:

Table 18.1.
Ligand Clusters Identified
Note prediction based on first cluster
Click on other clusters to view the potential sites associated with them
MAMMOTH Scores
Cluster

1

Ligands

I

I

4

2

Structures

1

2

Av

HSI

1

7.3

min

17.9

73

7.3

Predicted Binding Site
Residue

Amino

max

14.9

Heterogens"present in Predicted Binding Site
Heterogen

contact av distance

067

Count

source structures

NAG

1

2vco_A

MAN

3

2vco A.1klf H

18.2.
Heterogens present in Predicted Binding Site

Predicted Binding Site

Heterogen
Residue

acid

contact av distance

divergence

NAG

Count
1

source structures
linTl B

127 HIS
128 MET
129 SER

Prediction colour legend:

Other residues Predicted Binding Site

Conservation Score Colour legend; 0-0.15
0.51-0.60

110

0.16-0.30

0.31-0.40 0.41-0.5

0.61-0.70

0 71 0.80 0 81 1.00
.

-

.

-

ESA_02342:
Table 19.
Ligand Clusters Identified
Note prediction based on first cluster
Click on other clusters to view the potential sites associated with them
MAMMOTH Scores
Cluster
1

Ligands
4

I

I

Structures
2

Av
gglM

min
20 0

max
27.3

Heterogens present in Predicted Binding Site

Predicted Binding Site

Heterogen

Amino
contact av distance
acid

Residue

38 VAL

Count

source structures

NAG

1

2vco_A

MAN

3

Iklf H,2vco A

74 ASP
78 ASN
178 VAL
183 TYR

ESA_02359:
Table 20.
L.igand Clusters Identified
Note prediction based on first cluster
Click on other clusters to view the potential sites associated with them

MAMMOTH Scores

duster
1
2
3
4
5
6
1O
8
9
7
36
34
35
33
31
32
30

l-lgancis

t

1
L
S
.
1
L .. . 5... . 1
1
4
1
1_ _ _ _ _ 4_ _ _ _ _ i
5

3
2
2
2
2
1
1
1
1
1
1
1

Av

Structures
1
1
1
1
1
2
1
1
1
2
1
1
1

7.6
7.6
7.6
7.6
7.6
8 2
7.6
7.6
7.6
7.5
1
I

11 6

1

11.6
11 .5
11.4
11-4
9.4

1
1
I

1
1
1
1

Predicted Binding Site

min
7 6
7 6
7 6
7 6
7 6
8 0
7 6
7 6
7 6
7.4
12 7
116
116
115
114
11.4

91

acid

contact av distance

7.6
7 6
7 6
7.6
12 7
11 6
11 6
115
114
11.4
9 4

Heterogens present in Predicted Binding Site
Heterogen

Residue

9 4

max
7.6
7 6
7.6
7 6
7 6
8 4

divergence

CA

Count

source structures
2fwu A

GLY

92 ASP
93 LEU

Prediction colour legend

Other residues Predicted Binding Site

Conservation Score Colour legend 0-0.15
0.51-0.60

111

0.16-0.30

P.31-0.4PI0.41-0.5

0.61-0.70

0.71-0.8010.81-1.00

ESA_02541:
Table 21.
Ligand Clusters Identified
Note prediction based on first cluster
Click on other clusters to view the potential sites associated with them
MAMMOTH Scores
Cluster

1

Ligands

I

~A

Structures

I

2

Av

min

max

192

29 9

SOI

Heterogens present in Predicted Binding Site

Predicted Binding Site

Heterogen

Amino

Residue

Count

source structures

NAG

1

2vco_A

MAN

3

Iklf H,2vco A

Other residues Predicted Binding Site

Prediction colour legend

Conservation Score Colour legend 0-0 15

0.31-0.40

0 16-0.30

ESA_04070:
Table 22.
Ligand Clusters Identified
Note prediction based on first cluster
Click on other clusters to view the potential sites associated with them
MAMMOTH Scores
Cluster

Ligands

Structures

1

3

1

Av

tl-M

Predicted Binding Site
Residue

min

max

15 4

16 4

Heterogens present in Predicted Binding Site
Heterogen

Amino

112

Count

source structures

NAG

2vco_A

MAN

2vco A

Prediction colour legend

Other residues Predicted Binding Site

Conservation Score Colour legend 0-0 15

0 16-0 30

3.5 Further Analysis of the Putative C sakazakii FimH Proteins
3.5.2 Predicting Protein-Protein Interactions Usin2 STRING

ESA 01973:
ESA 01974
ESA 02539

ESA 01972

click for information on E

T

ESA 03812

ESA 03813

SA 02343

This is the confidence view. Stronger associations are represented by thicker lines.
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• ESA

01973

hypothetical protein (322 aa)

(Cronobactcr sakrazakiO

Predicted Functional Partners:

o
u

(/I

t? ESA_ 01974
• ESA_ 01975
ESA_ 01972

hypothetica
hypothetica
hypothetica

protein (795 aa)
protein (225 aa)
protein (176 aa)

I 0.966
I 0.863

• ESA_ 02540
ESA_ 03813

hypothetica
hypothetica

protein (820 aa)
protein (889 aa)

I 0.771 I

^ ESA_ 02539
ESA_ 02797
• ESA_ 02343

hypothetica
hypothetica
hypothetica

protein (223 aa)
protein (829 aa)
protein (846 aa)

i 0.758

• ESA_ 03815
<■» ESA 03814

hypothetica
hypothetica

protein (188 aa)
protein (231 aa)

■ 0.733
0.726

I 0.806;

; 0.759
; 0.749
; 0.734

Figure 40. STRING results for ESA_01973.

ESA 02342:

This is the confidence view. Stronger associations are represented by thicker lines.
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9 ESA 02342

hypothetical protein (342 aa)
(Cronobscter sakazakii)

Predicted Functional Partners:
©
©
5
©
©
©
©
©

ESA_02343
ESA_01359
ESA_00608
ESA_02345
ESA_02344
ESA_04295
ESA_pESA3p05458
ESA_02461
ESA_02868
ESA_02538

hypothetical
hypothetical
hypothetical
hypothetical
hypothetical
hypothetical
hypothetical
hypothetical
hypothetical
hypothetical

protein
protein
protein
protein
protein
protein
protein
protein
protein
protein

(846 aa)
(208 aa)
(95 aa)
(202 aa)
(224 aa)
(155 aa)
(92 aa)
(317 aa)
(446 a a)
(179 aa)

Vk.
ou
in
0.828
0,753
0.752
0.751
0,666
0.659
0.656
0.628
0.621
0.617

Figure 41. STRING results for ESA_02342,

ESA 02539:
ESA 04071
ESA 02538

ESA 03815

ESA 02799

ESA 01974

This is the confidence view. Stronger associations are represented by thicker lines.
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9 ESA_02539 hypothetical protein (223 aa)
(Cronobacter sakazakii)

ou

Predicted Functional Partners:
tS ESA_
9 ESA_
“ ESA_
: • ESA_
\9 ESA_
' 9 ESA.
ESA.
9 ESA.
9 ESA.
• ESA

02538
02540
02542
02541
03815
01976
03813
01974
04071
02799

hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica

protein
protein
protein
protein
protein
protein
protein
protein
protein
protein

(179
(820
(169
(335
(188
(176
(889
(795
(820
(178

V)

0.911
0.885
0.877
0.861
0.777
0.773
0.770
0.767
0.766
0.766

aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)

Figure 42. STRING results for ESA_ 02539.

ESA 02541:
ESA 02343

ESA 03814

ESA 02799

ESA 01974

This is the confidence view. Stronger associations are represented by thicker lines.
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• ESA_02541 hypothetical protein (335 aa)
(Cronobacter sakazafdi)

o
u

Predicted Functional Partners:
e
•
***
•
e
•

ESA_
ESA_
ESA_
ESA_
ESA_
ESA.
ESA.
• ESA.
• ESA.
® ESA

02540
02542
02539
03813
03815
01974
02799
02797
02343
03814

hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica

protein
protein
protein
protein
protein
protein
protein
protein
protein
protein

(820
(169
(223
(889
(188
(795
(178
(829
(846
(231

(/)

0.963'
0.944
0.861
0.775
0.774
0.763
0.755
0.741
0.740
0.734

aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)

Figure 43. STRING results for ESA__02541

ESA 04070:

ESA 04073

ESA 04069

ESA 00607

This is the confidence view. Stronger associations are represented by thicker lines.
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• ESA_04070 hypothetical protein (324 aa)
(Cronobacter s^kazefdi)

o

Predicted Functional Partners:
« ESA_ 04071
• ESA_ 04072
ESA_ 04069
• ESA_ 03815
■ ESA_ 00982
• ESA. 03812
ESA. 03813
• ESA. 03814
^ ESA. 04073
© ESA 00607

hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica
hypothetica

protein
protein
protein
protein
protein
protein
protein
protein
protein
protein

(820
(253
(187
(188
(331
(384
(889
(231
(196
(115

u

V)

0.957:

aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)
aa)

0.947!
0.819^
0.765
0.764
0.761
0.760
0.756
0.736
0.701

Figure 44. STRING results for ESA_04070.
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